Document:

EX-10.4

 Exhibit 10.4 

Execution Version 

SUBORDINATION AND INTERCREDITOR AGREEMENT 

This SUBORDINATION AND INTERCREDITOR AGREEMENT (as amended, restated, supplemented or otherwise modified, this “Agreement”)
dated as of February 24, 2020 by and among (i) Deerfield Private Design Fund IV, L.P., in its capacity as agent for the Facility Secured Parties (as defined below), including its successors and assigns in such capacity from time to time
(“Facility Agent”), (ii) Deerfield ELGX Revolver, LLC, in its capacity as administrative agent for the ABL Secured Parties (as defined below), including its successors and assigns in such capacity from time to time and any
“Third Party Agent” (as defined in the below-defined Facility Agreement) during any “Third Party Agent Retention Period” (as defined in the below-defined Facility Agreement) (“ABL Agent,” and together with the
Facility Agent, the “First Lien Agents” and each, a “First Lien Agent”), (iii) Wilmington Trust, National Association, a national banking association, in its capacity as collateral agent for itself and the other
Second Lien Creditors (as defined below), including its successors and assigns in such capacity from time to time (the “Second Lien Agent”), (iv) PCH Manager Manager Fund, SPC. – Segregated Portfolio 206, Corrib Master Fund,
Ltd., NPB Manager Manager Fund, SPC. – Segregated portfolio 107, Long Ball Partner, LLC, LMAP Kappa Limited (“Kappa”), Blackwell Partners-LLC_Series B (“MACK”) and Silverback Opportunistic Credit Master Fund Limited
(“SOCMF”), each a Second Lien Creditor, and (iv) Endologix, Inc., a Delaware corporation (“Endologix”). 

RECITALS: 

WHEREAS, Endologix, certain of the Subsidiaries of Endologix party thereto from time to time as “Loan Parties” (such
Subsidiaries, together with Endologix, the “Facility Loan Parties”), the lenders party thereto from time to time (such lenders, together with their successors and assigns, the “Facility Lenders”) and Facility Agent,
have entered into that certain Amended and Restated Facility Agreement, dated as of August 9, 2018 (as amended, restated, supplemented, modified, replaced or refinanced from time to time, the “Facility Agreement”), providing
for, among other things, a term loan facility to be available to Endologix thereunder. Capitalized terms used herein and not otherwise defined are used herein as defined in the Facility Agreement; 

WHEREAS, Endologix, certain of the Subsidiaries of Endologix party thereto from time to time as “Borrowers” (such
Subsidiaries, together with Endologix, the “ABL Borrowers”), the lenders party thereto from time to time (such lenders, together with their successors and assigns, the “ABL Lenders”) and ABL Agent, have entered into
that certain Credit Agreement, dated as of August 9, 2018 (as amended, restated, supplemented, modified, replaced or refinanced from time to time, the “ABL Agreement”), providing for, among other things, a revolving credit
facility to be available to the ABL Borrowers; 
 WHEREAS, the Facility Agent and the ABL Agent are parties to that certain
Intercreditor Agreement, dated as of August 9, 2018, as amended, restated, supplemented or otherwise modified from time to time (the “Intercreditor Agreement”); 

WHEREAS, Endologix, Wilmington Trust, National Association, a national banking association, in its capacity as trustee (the
“Trustee”), and the Second Lien Agent have entered into the Indenture, dated as of the date hereof (as amended, restated, supplemented, modified, replaced or refinanced from time to time, the “Second Lien
Agreement”), providing for, among other things, the issuance of the 5.0% Voluntary Convertible Senior Secured Notes due 2024 (the “Second Lien Notes”) and the granting by Endologix of certain liens on substantially all of
the Collateral (as defined below) under the Junior Lien Security Agreement (as defined below), which Second Lien Notes are being issued in exchange for 3.25% Convertible Notes previously issued by Endologix (the “Exchange”) and more
particularly described in that certain Exchange Agreement (as defined below); 
 WHEREAS, the obligations of Endologix and its
applicable Subsidiaries under the Facility Agreement and the other Facility Documents (as defined below) and the ABL Agreement and the other 

 ABL Documents (as defined below) are secured by Liens (as defined below) on substantially all of the assets
of Endologix and such Subsidiaries, including the First Lien Collateral (as defined below); 
 WHEREAS, the Facility Documents and
the ABL Documents provide, among other things, that any ABL Lien shall be pari passu in all respects with any Facility Lien, and any Facility Lien shall be pari passu in all respects with any ABL Lien; 

WHEREAS, in order to the induce Facility Agent, the Facility Secured Parties, the ABL Agent and the ABL Secured Parties to consent to
the Exchange, Second Lien Agent and each other Second Lien Creditor has agreed to the subordination and intercreditor arrangements and other terms and provisions set forth in this Agreement; and 

WHEREAS, pursuant to the terms of the February 2020 Exchange Agreement and Fourth Amendment, the Second Lien Agent, each other Second
Lien Creditor and Endologix are required to enter into this Agreement with the First Lien Agents. 
 NOW, THEREFORE, in consideration
of the foregoing, the mutual covenants, terms, and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows: 
 1. Definitions and Interpretation. 

1.1 Definitions. The following terms shall have the following meanings in this Agreement: 

“ABL Agent” has the meaning assigned to such term in the Preamble to this Agreement. 

“ABL Agreement” has the meaning assigned to such term in the Recitals to this Agreement. 

“ABL Borrowers” has the meaning assigned to such term in the Recitals to this Agreement. 

“ABL Collateral” means the “Collateral” (as defined in the ABL Agreement) and all other assets and
property pledged (or purported to be pledged) or granted a Lien on (or purported to be granted a Lien on) by the ABL Loan Parties to (and for the benefit of) the ABL Secured Parties under the ABL Documents. 

“ABL Documents” means the ABL Agreement, the other “Loan Documents” (as defined in the ABL
Agreement) and all other agreements, instruments and documents related to the ABL Agreement, as amended, restated, supplemented or otherwise modified from time to time. 

“ABL Event of Default” means any “Event of Default” (as defined in ABL Agreement). 

“ABL Lenders” has the meaning assigned to such term in the Recitals to this Agreement. 

“ABL Liens” means all Liens pledged (or purported to be pledged) or granted (or purported to be granted) to
the ABL Secured Parties under the ABL Documents on the Collateral securing the ABL Obligations. 
 “ABL Loan
Parties” means the ABL Borrowers and the other “Loan Parties” (as defined in the ABL Agreement). 

  
 2 

 “ABL Loans” means the “Loans” (as defined in the
ABL Agreement). 
 “ABL Obligations” means all “Obligations” (as defined in the ABL Agreement),
any debtor-in-possession financing furnished by the ABL Lenders after the commencement of an Insolvency Proceeding, and all other indebtedness, liabilities and other
obligations owed or incurred by the ABL Loan Parties under the ABL Documents, including all interest accrued or accruing (or which would, absent commencement of an Insolvency Proceeding, accrue) after commencement of an Insolvency Proceeding in
accordance with the rate specified in the relevant ABL Document, whether or not the claim for such interest is allowed as a claim in such Insolvency Proceeding. 

“ABL Required Lenders” means the “Required Lenders” (as defined in the ABL Agreement). 

“ABL Revolving Loan Commitments” means the “Revolver Commitments” (as defined in the ABL Agreement).

 “ABL Secured Parties” means ABL Agent, the ABL Lenders, the “Indemnified Persons” (as defined
in the ABL Agreement), the other members of the “Lender Group” (as defined in the ABL Agreement) and any other holders of the ABL Obligations. 

“Agreement” has the meaning assigned to such term in the Preamble to this Agreement. 

“Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy,” as now and
hereafter in effect, or any successor statute. 
 “Collateral” means solely the personal property First Lien
Collateral of Endologix pledged (or purported to be pledged) or granted a Lien on (or purported to be granted a Lien on) by Endologix to (and on behalf of) the ABL Secured Parties under the ABL Documents and to (and on behalf of) the Facility
Secured Parties under the Facility Documents. 
 “Discharge of ABL Obligations” means: 

(a) payment in full in cash of the principal of and interest (including interest accruing on or after the commencement of any
Insolvency Proceeding, whether or not such interest would be allowed in such Insolvency Proceeding) and any fees on all ABL Obligations; 

(b) payment in full in cash of all other outstanding ABL Obligations (other than unasserted contingent indemnification
obligations), including any that are due and payable or otherwise accrued and owing at or prior to the time such principal, interest and fees are paid; and 

(c) permanent termination or permanent expiration of all commitments, if any, to extend credit (including the ABL Revolving
Loan Commitments) by any ABL Secured Party under the ABL Documents. 
 “Discharge of Facility Obligations”
means: 
 (a) payment in full in cash of the principal of and interest (including interest accruing on or after the
commencement of any Insolvency Proceeding, whether or not such interest would be allowed in such Insolvency Proceeding), any fees and any Facility Non-Callable Make Whole Amount on all Facility Obligations
(other than (i) any unasserted contingent indemnification obligations and (ii) any amounts owed under any Warrant or the Registration 

  
 3 

 
Rights Agreement that are not due or payable at the time when all other Facility Obligations are paid in full in cash); 

(b) payment in full in cash of all other outstanding Facility Obligations (other than (i) any unasserted contingent
indemnification obligations and (ii) any amounts owed under any Warrant or the Registration Rights Agreement that are not due or payable at the time when all other Facility Obligations are paid in full in cash), including any that are due and
payable or otherwise accrued and owing at or prior to the time such principal, interest and fees and any applicable Facility Non-Callable Make Whole Amount, any Facility CoC Fee, and the First Out Waterfall
Restructuring Payment, are paid; and 
 (c) permanent termination or permanent expiration of all commitments, if any, to
extend credit by any Facility Secured Party under the Facility Documents. 
 “Distribution” means, with
respect to any indebtedness, obligation or security, including the Second Lien Obligations (a) any payment or distribution by any Person of cash, securities or other property, by set-off or otherwise, on
account of such indebtedness, obligation or security, or (b) any redemption, purchase or other acquisition of such indebtedness, obligation or security by any Person. 

“Exchange” has the meaning assigned to such term in the Recitals to this Agreement. 

“Exchange Agreement” means that certain Exchange Agreement dated as of the date hereof by and among Endologix
and the Second Lien Noteholders. 
 “Facility Agent” has the meaning assigned to such term in the Preamble
to this Agreement. 
 “Facility Agreement” has the meaning assigned to such term in the Recitals to this
Agreement. 
 “Facility Collateral” means the “Collateral” (as defined in the Facility Agreement)
and all other assets and property pledged (or purported to be pledged) or granted a Lien on (or purported to be granted a Lien on) by the Facility Loan Parties to (and for the benefit of) the Facility Secured Parties under the Facility Documents.

 “Facility Documents” means the Facility Agreement, the other “Loan Documents” (as defined in
the Facility Agreement) and all other agreements, instruments and documents related to the Facility Agreement, as amended, restated, supplemented or otherwise modified from time to time. 

“Facility Event of Default” means “Event of Default” (as defined in the Facility Agreement). 

“Facility Lenders” has the meaning assigned to such term in the Recitals to this Agreement. 

“Facility Liens” means all Liens pledged (or purported to be pledged) or granted (or purported to be granted)
to the Facility Secured Parties under the Facility Documents on the Facility Collateral securing the Facility Obligations. 

“Facility Loan Parties” has the meaning assigned to such term in the Recitals to this Agreement. 

  
 4 

 “Facility Loans” means “Loans” (as defined in the
Facility Agreement). 
 “Facility Non-Callable Make Whole Amount”
means any “Non-Callable Make Whole Amount” (as defined in the Facility Agreement). 

“Facility Obligations” means all “Obligations” (as defined in the Facility Agreement), any debtor-in-possession financing furnished by the Facility Lenders after the commencement of an Insolvency Proceeding, and all other indebtedness, liabilities and other
obligations owed or incurred by the Facility Loan Parties under the Facility Documents (including any Facility Non-Callable Make Whole Amount, any Facility CoC Fee and the First Out Waterfall Restructuring
Payment), including all interest accrued or accruing (or which would, absent commencement of an Insolvency Proceeding, accrue) after commencement of an Insolvency Proceeding in accordance with the rate specified in the relevant Facility Document
whether or not the claim for such interest is allowed as a claim in such Insolvency Proceeding. 
 “Facility Secured
Parties” means the Facility Agent, the Facility Lenders, the other “Secured Parties” (as defined in the Facility Agreement) and any other holders of Facility Obligations. 

“First Lien Agent” or “First Lien Agents” has the meaning assigned to such term in the
Preamble to this Agreement. 
 “First Lien Collateral” means all of the assets and property of any
Grantor, whether real, personal or mixed, constituting both ABL Collateral and Facility Collateral. 
 “First Lien
Credit Agreement” means the Facility Agreement and the ABL Agreement, as the context requires. 
 “First
Lien Creditors” means, collectively, the Facility Agent, Facility Lenders, the ABL Agent and ABL Lenders, and each other holder from time to time of the First Lien Obligations. 

“First Lien Creditors’ Rights and Remedies” has the meaning set forth in Section 9.8. 

“First Lien Event of Default” means any ABL Event of Default or Facility Event of Default. 

“First Lien Loan Documents” means (i) with respect to the Facility Agent and the Facility Lenders, the
Facility Documents and (ii) with respect to the ABL Agent and the ABL Lenders, the ABL Documents, and (iii) in each case, after any refinancing of the First Lien Obligations under such First Lien Loan Documents, the applicable refinancing
documents. 
 “First Lien Obligations” means, collectively, the Facility Obligations and the ABL
Obligations. 
 “Grantors” means, collectively, the ABL Loan Parties and the Facility Loan Parties. 

“Insolvency Proceeding” means: 

(a) any voluntary or involuntary case or proceeding under the Bankruptcy Code with respect to any Grantor; 

  
 5 

 (b) any other voluntary or involuntary insolvency, reorganization or
bankruptcy case or proceeding, or any receivership, liquidation, reorganization or other similar case or proceeding, with respect to any Grantor or with respect to its assets or property; 

(c) any liquidation, dissolution, reorganization or winding up of any Grantor whether voluntary or involuntary and whether or
not involving insolvency or bankruptcy; or 
 (d) any assignment for the benefit of creditors or any other marshalling of
assets and liabilities of any Grantor. 
 “Junior Lien Security Agreement” means the Junior Lien Security
Agreement dated as of the date hereof between Endologix and the Second Lien Agent. 
 “Lien” means any lien,
pledge, preferential arrangement, mortgage, security interest, deed of trust, charge, assignment, hypothecation, title retention or other encumbrance on or with respect to assets, property or interest in assets or property having the practical
effect of constituting a security interest, in each case with respect to the payment of any obligation with, or from the proceeds of, any asset or revenue of any kind. For purposes of this Agreement, any Grantor or any Subsidiary shall be deemed to
own subject to a Lien any asset which it has acquired or holds subject to the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 

“Loan Documents” means, collectively, the ABL Documents and the Facility Documents, as the context may so
require. 
 “Loans” means the ABL Loans and the Facility Loans, as the context may so require. 

“Obligations” means the ABL Obligations and the Facility Obligations, as the context may so require. 

“Paid in Full” or “Payment in Full” means, collectively, Discharge of Facility Obligations and
Discharge of ABL Obligations. 
 “Person” means and includes any natural person, individual, partnership,
joint venture, corporation, trust, limited liability company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

“Registration Rights Agreement” means the “Registration Rights Agreement” (as defined in the
Facility Agreement). 
 “Release Document” has the meaning set forth in Section 2.3. 

“Second Lien Agreement” has the meaning assigned to such term in the Recitals to this Agreement. 

“Second Lien Agent” has the meaning assigned to such term in the Preamble to this Agreement. 

“Second Lien Collateral” means the “Collateral” (as defined in the Junior Lien Security Agreement)
and all other assets and property pledged (or purported to be pledged) or granted a Lien on (or purported to be granted a Lien on) by Endologix to (and for the benefit of) the Second Lien Creditors under the Second Lien Documents. 

  
 6 

 “Second Lien Creditor” means, collectively, the Second Lien
Agent, the Trustee, the Second Lien Noteholders and each other holder from time to time of the Second Lien Obligations. 

“Second Lien Documents” means the Exchange Agreement, the Second Lien Agreement, the Second Lien Notes, the
Second Lien Security Documents and all agreements, documents, and instruments entered into in connection therewith. 

“Second Lien Event of Default” means any “Event of Default” as such term is defined in any of the
Second Lien Documents. 
 “Second Lien Noteholders” means the holders of the convertible notes issued by
Endologix under the Second Lien Agreement. 
 “Second Lien Notes” has the meaning assigned to such term in
the Recitals to this Agreement. 
 “Second Lien Obligations” means any principal, premium, interest
(including any interest and fees accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest or fees is an
allowed or allowable claim under applicable law), penalties, fees, indemnifications, reimbursements, damages and other liabilities, and guarantees of payment of such principal, interest, penalties, fees, indemnifications, reimbursements, damages and
other liabilities payable under any of the Second Lien Documents. 
 “Second Lien Security Documents” means
the “Security Documents” as defined in the Second Lien Agreement. 
 “Standstill Period” has the
meaning set forth in Section 3.1. 
 “Subsidiary” or “Subsidiaries” means, with
respect to any Person, (a) any corporation of which an aggregate of more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of
whether, at the time, capital stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such
Person or one or more Subsidiaries of such Person, or with respect to which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of the aggregate voting power of such capital stock, whether by proxy,
agreement, operation of law or otherwise, and (b) any partnership or limited liability company in which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits
or capital contribution) of more than fifty percent (50%) or of which any such Person is a general partner, manager or managing member or may exercise the powers of a general partner, manager or managing member. Unless the context otherwise
requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Grantor. 
 “UCC” means
the Uniform Commercial Code (or any similar or equivalent legislation) as in effect from time to time in any applicable jurisdiction or, if the applicable jurisdiction shall not have any Uniform Commercial Code, the Uniform Commercial Code as in
effect from time to time in the State of New York. 
 1.2 Terms Generally. 

  
 7 

 (a) All terms defined in the UCC, unless otherwise defined herein, shall
have the meanings set forth therein. 
 (b) The definitions of terms in this Agreement shall apply equally to the singular
and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The use of the words “include,” “includes” and “including” shall
be by way of example rather than limitation, and such words shall be deemed to be followed by the phrase “without limitation.” The word “will” shall be construed to have the same meaning and effect as the word “shall.”
Unless the context requires otherwise: 
 (i) any definition of or reference to any agreement, instrument, or other document
herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, restated, supplemented, modified, renewed, replaced or extended; 

(ii) any reference herein to any Person shall be construed to include such Person’s permitted successors and assigns;

 (iii) the words “herein,” “hereof” and “hereunder,” and words of similar import, shall be
construed to refer to this Agreement in its entirety and not to any particular provision hereof; 
 (iv) any references to
sections, subsections, clauses or paragraphs shall be references to sections, subsections, clauses and paragraphs in this Agreement; 

(v) the term “or” has, except where otherwise indicated, the inclusive meaning represented by the phrase
“and/or”; and 
 (vi) the words “asset” and “property” shall be construed to have the same
meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. 

2. Lien Priorities and Security Interests. 

2.1 Seniority of Liens Securing First Lien Obligations. Until the First Lien Obligations have been Paid in Full, each
Second Lien Creditor’s security interest in and Lien on the Collateral to secure the Second Lien Obligations shall be and hereby are subordinate for all purposes and in all respects to each of the First Lien Agent’s security interests in
and Liens on the Collateral to secure the First Lien Obligations, regardless of the order or time of attachment, or the order, time or manner of perfection, or the order or time of filing or recordation of any document or instrument, or other method
of perfecting a Lien. The Lien priorities set forth in the immediately preceding sentence shall not be altered or otherwise affected by any amendment, modification, supplement, extension, renewal, restatement, replacement or refinancing of any of
the First Lien Obligations or the Second Lien Obligations, by any failure to perfect the First Lien Agents’ respective security interests in the Collateral, the subordination of the First Lien Agents’ respective Liens on the Collateral,
the avoidance or invalidation of the First Lien Agents’ respective Liens, or by any other action or inaction which any First Lien Creditor may take or fail to take with respect to the Collateral. 

2.2 Perfection; Prohibition on Contesting Liens. Each of the First Lien Agents, for itself and on behalf of each First
Lien Creditor, and the Second Lien Agent, for itself and on behalf of each Second Lien Creditor, agrees that it owes no responsibility to the other for perfecting and 

  
 8 

 
maintaining the perfection of its Lien on each item constituting the Collateral. Further, in no event shall the Second Lien Agent or any Second Lien Creditor knowingly take, accept or perfect any
Lien in any property unless the First Lien Agents also shall have a perfected Lien in such property. If the Second Lien Agent or any Second Lien Creditor obtains possession of or otherwise receives any Collateral or proceeds thereof in violation of
the foregoing or any other term of this Agreement, then such Collateral and proceeds shall be held in trust by the Second Lien Agent or such Second Lien Creditor for the benefit of the First Lien Agents and turned over promptly to the First Lien
Agents in the form so received (with any necessary endorsements). This Agreement is intended solely to govern the respective Lien priorities as between the First Lien Agents and First Lien Creditors on the one hand and the Second Lien Agent and the
Second Lien Creditors on the other hand and shall not impose on any First Lien Agent or any other First Lien Creditor or the Second Lien Agent or any other Second Lien Creditor any obligations in respect of the disposition of proceeds of foreclosure
of any Collateral which would conflict with prior perfected claims thereon in favor of any other Person or any order or decree of any court or other governmental authority or any applicable law. Each of the Second Lien Agent and each other Second
Lien Creditor agrees that it will not at any time contest the validity, perfection, priority, or enforceability of any of the First Lien Obligations, the First Lien Loan Documents or the Liens and security interests of the First Lien Agents in the
Collateral securing the First Lien Obligations. 
 2.3 Agreement to Release Liens. Notwithstanding anything to the
contrary contained in any agreement between any Second Lien Creditor and Endologix, until the First Lien Obligations have been Paid in Full, only the First Lien Agents (and each of them) shall have the right to restrict or permit, or approve or
disapprove, the sale, transfer, release or other disposition of the Collateral or take any action with respect to the Collateral, which right any of the First Lien Agents may exercise without any consultation with or consent of the Second Lien Agent
or any Second Lien Creditor. In the event that any of the First Lien Agents releases or agrees to release any of its Liens or security interests in any portion of the Collateral in connection with the sale or other disposition thereof, or any of the
Collateral is sold or retained pursuant to a foreclosure or similar action, the liens securing the Second Lien Obligations shall automatically be released and the Second Lien Agent for itself and on behalf of each Second Lien Creditor shall promptly
consent to such sale or other disposition and promptly execute and deliver to such First Lien Agent such consent to such sale or other disposition, any and all documents and instruments which may be necessary or desirable to accomplish the purposes
of this Section, including authorizing such First Lien Agent to file any terminations of financing statements, partial lien releases, mortgage satisfactions and discharges, endorsements, assignments or other instruments of transfer, termination or
release (collectively, “Release Documents”), as such First Lien Agent shall reasonably request to effect the release of the Liens and security interests of the Second Lien Agent in such Collateral. In the event of any sale, transfer
or other disposition (including a casualty loss or taking through eminent domain) of the Collateral, the proceeds resulting therefrom (including insurance proceeds) shall be applied in accordance with the terms of the First Lien Loan Documents until
such time as the First Lien Obligations have been Paid in Full. 
 2.4 Power of Attorney. The Second Lien Agent and
each Second Lien Creditor hereby irrevocably constitutes and appoints each First Lien Agent, with full power of substitution, as its true and lawful attorney-in-fact
with full irrevocable power and authority in the place and stead of the Second Lien Agent and the Second Lien Creditors and in the name of the Second Lien Agent and the Second Lien Creditors or in such First Lien Agent’s own name, from time to
time in such First Lien Agent’s discretion, solely for the purpose of carrying out the terms of Section 2.3 hereof, to take any and all appropriate action and to execute any and all Release Documents, and, in addition, to take any and all
other appropriate and commercially reasonable action for the purpose of carrying out the terms of such Sections, such power of attorney being coupled with an interest and irrevocable. The Second Lien Agent and the Second Lien Creditors hereby ratify
all that said attorneys shall lawfully 

  
 9 

 
do or cause to be done pursuant to the power of attorney granted in this Section 2.4. No Person to whom this power of attorney is presented, as authority for the First Lien Agent to take any
action or actions contemplated hereby, shall be required to inquire into or seek confirmation from any Second Lien Creditor as to the authority of such First Lien Agent to take any action described herein, or as to the existence of or fulfillment of
any condition to this power of attorney, which is intended to grant to such First Lien Agent the authority to take and perform the actions contemplated herein. The Second Lien Agent and the Second Lien Creditors irrevocably waive any right to
commence any suit or action, in law or equity, against any Person that acts in reliance upon or acknowledges the authority granted under this power of attorney. 

2.5 Legends. Until the First Lien Obligations are Paid in Full, each of the Second Lien Notes at all times shall contain
in a conspicuous manner the following legend: 
 “THE LIEN AND SECURITY INTEREST GRANTED TO THE HOLDER OF THIS NOTE ARE SUBJECT TO THE
TERMS AND CONDITIONS OF THAT CERTAIN SUBORDINATION AND INTERCREDITOR AGREEMENT DATED AS OF FEBRUARY 24, 2020 (THE “SUBORDINATION AGREEMENT”) AMONG THE COMPANY, THE COLLATERAL AGENT, THE OTHER SECOND LIEN CREDITORS AND THE FIRST LIEN AGENTS
(AS DEFINED IN THE SUBORDINATION AGREEMENT) AND EACH HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF, SHALL BE BOUND BY THE PROVISIONS OF THE SUBORDINATION AGREEMENT.” 

3. Enforcement. 

3.1 Exercise of Remedies. Until the First Lien Obligations have been Paid in Full, each First Lien Agent shall have the
exclusive right to manage, perform and enforce (or not enforce) the terms of the respective First Lien Loan Documents with respect to the Collateral, to exercise and enforce all privileges and rights thereunder in such order and manner as it may
determine in its sole discretion, including the exclusive right to take or retake control or possession of any Collateral and to make determinations regarding the release, disposition, or restrictions with respect to any Collateral, without any
consultation with or the consent of the Second Lien Agent or any Second Lien Creditor. In that regard, no Second Lien Creditor shall, without the prior written consent of the First Lien Agents (i) exercise or seek to exercise any rights or
remedies (including setoff) with respect to any Collateral in respect of any Second Lien Obligations, or institute any action or proceeding with respect to such rights or remedies (including any action of foreclosure), (ii) contest, protest or
object to any foreclosure proceeding or action brought with respect to the Collateral by any First Lien Agent or any other First Lien Creditor in respect of the First Lien Obligations, or any other exercise by any such party of any rights and
remedies relating to the Collateral under the First Lien Loan Documents or otherwise in respect of the First Lien Obligations, or (iii) object to the forbearance by the First Lien Creditors from bringing or pursuing any foreclosure proceeding
or action or any other exercise of any rights or remedies relating to the Collateral in respect of First Lien Obligations. Notwithstanding the foregoing, the Second Lien Agent may, subject to Section 8.2 of this Agreement, file and defend
proofs of claim against Endologix in any Insolvency Proceeding involving Endologix. No First Lien Creditor shall have any liability to any Second Lien Creditor in respect of any Second Lien Creditor’s failure to obtain repayment in full of the
Second Lien Obligations. Notwithstanding the foregoing, any Second Lien Creditor may exercise or seek to exercise any rights or remedies with respect to any Collateral in respect of any Second Lien Obligations after the passage of a period of 360
days (the “Standstill Period”) from the date of delivery of a written notice to the First Lien Agent of such Second Lien Creditor’s intention to exercise such rights, which notice may only be delivered following the occurrence
of and during the continuation of a Second Lien Event of Default; provided that, notwithstanding the foregoing, in no 

  
 10 

 
event shall any Second Lien Creditor exercise or continue to exercise any such rights or remedies if, notwithstanding the expiration of the Standstill Period, (a) any First Lien Creditor
shall have commenced and be pursuing the exercise of rights and remedies with respect to any of the Collateral, or (b) an Insolvency Proceeding shall have been commenced in respect of Endologix; provided, further, that in any Insolvency
Proceeding commenced by or against Endologix, the Second Lien Creditors may take any action only as expressly permitted by Section 8.2. 

3.2 Rights as Unsecured Creditors. The Second Lien Agent and the other Second Lien Creditors may exercise rights and
remedies as unsecured creditors against Endologix in accordance with the terms of the Second Lien Documents and applicable law, so long as such rights and remedies do not violate any provision of this Agreement. Nothing in this Agreement shall
prohibit the receipt by the Second Lien Agent or any other Second Lien Creditor of the required payments of principal, premium, interest, fees, and other amounts due under the Second Lien Documents, so long as such receipt (a) is not the direct
or indirect result of the exercise in contravention of this Agreement by the Second Lien Agent or any other Second Lien Creditor of rights or remedies as a secured creditor in respect of the Collateral and (b) whether in contravention of this
Agreement or not, does not have the effect of discharging any Lien of any First Lien Agent or any other First Lien Creditor on the Collateral. In the event the Second Lien Agent or any other Second Lien Creditor becomes a judgment lien creditor in
respect of the Collateral as a result of its enforcement of its rights as an unsecured creditor in respect of Second Lien Obligations, such judgment lien shall be subordinated to the Liens securing the First Lien Obligations on the same basis as the
other Liens securing the Second Lien Obligations are so subordinated to such Liens securing the First Lien Obligations under this Agreement. 

4. Payments. 

4.1 Application of Collateral Proceeds. If a First Lien Event of Default shall have occurred and be continuing, so long
as the First Lien Obligations have not been Paid in Full and whether or not any Insolvency Proceeding has been commenced by or against Endologix or any other Grantor, the Collateral and any proceeds received in connection with the sale or other
disposition of, or collection on, the Collateral upon the exercise of remedies shall be applied by the First Lien Agents to the First Lien Obligations in such order as specified in the First Lien Loan Documents until the First Lien Obligations shall
have been Paid in Full. When the First Lien Obligations have been Paid in Full, each First Lien Agent shall deliver promptly to the Second Lien Agent any Second Lien Collateral or proceeds thereof held by it in the same form as received, with any
necessary endorsements, or as a court of competent jurisdiction may otherwise direct, to be applied by the Second Lien Agent to the Second Lien Obligations in such order as specified in the relevant Second Lien Document. 

4.2 Payments Over. Unless and until the First Lien Obligations shall have been Paid in Full and whether or not any
Insolvency Proceeding has been commenced by or against Endologix or any other Grantor, the Collateral and any proceeds thereof received by the Second Lien Agent or any other Second Lien Creditor in connection with the exercise of any right or remedy
(including setoff) relating to the Collateral, in contravention of this Agreement or otherwise, shall be segregated and held in trust for the benefit of, and immediately paid over to, the First Lien Agents for the benefit of the First Lien Creditors
in the same form as received, with any necessary endorsements, or as a court of competent jurisdiction may otherwise direct, and be applied in accordance with the terms of the Intercreditor Agreement. Each First Lien Agent is hereby authorized to
make any such endorsements as agent for each of the Second Lien Agent and any other Second Lien Creditor. This authorization is coupled with an interest and is irrevocable. 

5. Modifications and Amendments. 

  
 11 

 5.1 Modifications to First Lien Loan Documents. Each First Lien Agent
may at any time and from time to time without the consent of or notice to the Second Lien Agent, without incurring liability to any Second Lien Creditor, and without impairing or releasing the obligations of the Second Lien Agent or any Second Lien
Creditor under this Agreement, change the manner or place of payment, or extend the time of payment of, or renew or alter any of the terms of the First Lien Obligations (including any increase in the amount thereof, any increase the interest rate
applicable thereto or the payment of any additional fees in connection therewith), or amend, restate, supplement, or otherwise modify in any manner any First Lien Loan Document. 

5.2 Modifications to Junior Loan Documents. Until the First Lien Obligations have been Paid in Full, and notwithstanding
anything to the contrary contained in the Second Lien Documents, Endologix, the Second Lien Agent and the Second Lien Creditors shall not, without the prior written consent of the First Lien Agents, agree to any amendment, restatement, supplement or
other modification to the Second Lien Documents if such amendment, modification, or supplement the effect of which is (a) to alter any subordination provision; (b) to obtain any guarantee from Persons that do not (or shall not after giving
effect to any such guarantee) guarantee the First Lien Obligations unless the requisite First Lien Creditors under the First Lien Credit Agreements shall have previously agreed to not obtain such guarantee; (c) to take any Liens in any assets
of any Grantor (other than subordinate Liens in any assets of Endologix permitted by, and at all times subject to, the terms of this Agreement); or (d) in contravention of or prohibited by the terms of the First Lien Loan Documents. 

6. Waiver of Certain Rights over Collateral by Second Lien Agent. 

6.1 Marshalling. The Second Lien Agent, on behalf of itself and the other Second Lien Creditors, hereby waives any
rights it may have under applicable law to assert the doctrine of marshalling or to otherwise require any First Lien Agent to marshal any property of Endologix for the benefit of the Second Lien Creditors. 

6.2 Rights Relating to Each First Lien Agent’s Actions Regarding the Collateral. The Second Lien Agent, on behalf
of itself and the other Second Lien Creditors, hereby waives, to the extent permitted by applicable law, any rights which it may have to enjoin or otherwise obtain a judicial or administrative order preventing any First Lien Agent from taking, or
refraining from taking, any action with respect to all or any part of the Collateral. Without limitation of the foregoing, each of the Second Lien Agent and each other Second Lien Creditor hereby agrees that (a) it has no right to direct or
object to the manner in which any First Lien Agent applies the proceeds of the Collateral resulting from the exercise by such First Lien Agent of rights and remedies under the First Lien Loan Documents and (b) no First Lien Agent has assumed
any obligation to act as the agent for the Second Lien Agent or any other Second Lien Creditor with respect to the Collateral. The First Lien Agents shall not have, by reason of this Agreement or any other document, a fiduciary relationship in
respect of any Second Lien Creditor. Except as expressly set forth in Section 6.4 below in respect of the perfection of Second Liens, each Second Lien Creditor agrees that no First Lien Agent has assumed any obligations to act, and does not
act, as agent, fiduciary, bailee or custodian for any Second Lien Creditor with respect to any of the Collateral or other property for any purposes, including, without limitation, for purposes of perfecting any Second Lien or holding, disposing,
managing or liquidating any Collateral. The First Lien Agents shall have the exclusive right to enforce rights and exercise remedies with respect to the Collateral until the First Lien Obligations have been Paid in Full. In exercising rights and
remedies with respect to the Collateral, the First Lien Agents may enforce the provisions of the First Lien Loan Documents and exercise remedies thereunder, all in such order and in such manner as they may determine in their sole discretion and in
accordance with the terms of the Intercreditor Agreement. Such exercise and enforcement shall include the rights to sell or otherwise dispose of Collateral, to incur expenses in 

  
 12 

 
connection with such sale or disposition and to exercise all the rights and remedies of a secured lender under the UCC. In conducting any public or private sale under the UCC, any First Lien
Agent shall give the Second Lien Agent written notice of such sale; provided, however, that 10 (ten) days’ notice shall be deemed to be commercially reasonable notice. 

6.3 Preservation of Rights. No First Lien Agent shall have any duty to protect or preserve any rights pertaining to any
of the Collateral in its possession and no First Lien Agent shall have any liability to the Second Lien Agent or any other Second Lien Creditor for any claims and liabilities at any time arising with respect to the Collateral in its possession. 

6.4 Bailee for Perfection. 

(a) Each First Lien Agent and Second Lien Agent each agree to hold or control that part of the Collateral that is in its possession or control
(or in the possession or control of its agents or bailees) to the extent that possession or control thereof is taken to perfect a Lien thereon under the UCC or other applicable law (such Collateral being referred to as the “Pledged
Collateral”), as bailee and as a non-fiduciary representative for Second Lien Agent or First Lien Agent, as applicable (such bailment and agency being intended, among other things, to satisfy the
requirements of Sections 8-301(a)(2), 9-313(c), 9-104, 9-105, 9-106, and 9-107 of the UCC), solely for the purpose of perfecting the security interest granted under the Second Lien Documents or the First Lien Loan Documents, as applicable, subject
to the terms and conditions of this Section 6.4. Unless and until the First Lien Obligations are Paid in Full, the Second Lien Agent agrees to promptly notify the First Lien Agents of any Pledged Collateral held by it or by any other Second Lien
Creditor of which it has knowledge, and, promptly upon the request of any First Lien Agent at any time prior to the Payment in Full of the First Lien Obligations, the Second Lien Agent agrees to deliver to any First Lien Agent any such Pledged
Collateral held by it or received by it from any other Second Lien Creditor, together with any necessary endorsements (or otherwise allow the First Lien Agents to obtain control of such Pledged Collateral). Nothing in this Section 6.4 shall
affect the relative priorities in and to the Collateral, all of which shall be governed by Section 2.1 of this Agreement. 
 (b) No
First Lien Agent shall have any obligation whatsoever to Second Lien Agent or any other Second Lien Creditor to ensure that the Pledged Collateral is genuine or owned by Endologix or to preserve rights or benefits of any Person except as expressly
set forth in this Section 6.4. Each of the Second Lien Agent and the other Second Lien Creditors hereby waives and releases each First Lien Agent from all claims and liabilities arising out of, or relating to, any First Lien Agent’s role under
this Section 6.4 as bailee or agent with respect to any Collateral (except to 

  
 13 

 
the extent resulting from such First Lien Agent’s gross negligence or willful misconduct as determined by a court of competent jurisdiction by a final and non-appealable judgment). Each of
the First Lien Agent and the other First Lien Creditors hereby waives and releases the Second Lien Agent from all claims and liabilities arising out of, or relating to the Second Lien Agent’s role under this Section 6.4 as bailee or agent with
respect to any Collateral (except to the extent resulting from the Second Lien Agent’s gross negligence or willful misconduct as determined by a court of competent jurisdiction by a final and non-appealable judgment). Second Lien Agent shall
have no obligation whatsoever to any First Lien Agent or any First Lien Creditor to ensure that the Pledged Collateral is genuine or owned by Endologix or to preserve rights or benefits of any Person except as expressly set forth in this Section
6.4. The duties or responsibilities of the First Lien Agents under this Section 6.4 shall be limited solely to holding or controlling the Pledged Collateral as bailee and non-fiduciary representative in accordance with this Section 6.4 and
delivering the Pledged Collateral upon a Payment in Full of First Lien Obligations as provided in Section 6.5. The duties or responsibilities of Second Lien Agent under this Section 6.4 shall be limited solely to holding or controlling the Pledged
Collateral as bailee and non-fiduciary representative in accordance with this Section 6.4 and Section 2.2. 
 (c) No First Lien Agent acting
pursuant to this Section 6.4 (or otherwise) shall have by reason of any First Lien Loan Documents, the Second Lien Documents, or this Agreement a fiduciary relationship in respect of Second Lien Agent or any other Second Lien Creditor. Second Lien
Agent acting pursuant to this Section 6.4 shall not have by reason of the First Lien Loan Documents, the Second Lien Documents, or this Agreement a fiduciary relationship in respect of First Lien Agent or any other First Lien Creditor. 

(d) Upon the Payment in Full of First Lien Obligations, the First Lien Agents shall, to the extent permitted by applicable law, at the sole
cost and expense of Endologix (or, if Endologix fails to pay such costs and expenses, at the cost and expense of the Second Lien Creditors other than the Second Lien Agent and the Trustee), deliver the remaining tangible Pledged Collateral (if any)
together with any necessary endorsements (including taking other action reasonably requested by Second Lien Agent to amend any control agreements), first, to Second Lien Agent to the extent the Second Lien Obligations remain outstanding as confirmed
in writing by Second Lien Agent, and second, to Endologix to the extent no First Lien Obligations or Second Lien Obligations remain outstanding (in each case, so as to allow such Person to obtain possession or control of such Pledged Collateral).

 6.5 Transfer of Pledged Collateral to Second Lien Agent. 

(a) The First Lien Agents hereby agree that upon the Payment in Full of the First Lien Obligations which is not accompanied by the payment in
full of the Second Lien Obligations, to the extent permitted by applicable law, upon the written request of Endologix or of Second Lien Agent (with all costs and expenses in connection therewith to be for the account of Endologix (or, if Endologix
fails to pay such costs and expenses, at the cost and expense of the Second Lien Creditors other than the Second Lien Agent and the Trustee): 

(i) Each First Lien Agent shall, without recourse or warranty, take commercially reasonable steps to transfer the possession
and control of the Pledged Collateral, if any, then in its possession or control to Second Lien Agent, except in the event and to the extent (A) such Collateral is sold, liquidated, or otherwise disposed of by any First Lien Agent or any other First
Lien Creditor or by Endologix as provided herein or in any other First Lien Loan Document in full or partial satisfaction of any of the First Lien 

  
 14 

 Obligations or (B) it is otherwise required by any order of any court or other governmental
authority or applicable law; and 
 (ii) in connection with the terms of any collateral access agreement, whether with a
landlord, processor, warehouseman, or other third party or any control agreement, the First Lien Agents shall notify the other parties thereto that its rights thereunder have been assigned to Second Lien Agent (to the extent such assignment is not
prohibited by the terms of such agreement) and shall confirm to such parties that Second Lien Agent is thereafter the “Lender” and/or “Secured Party” (or other comparable term) as such term is used in any such agreement and is
otherwise entitled to the rights of the secured party under such agreement. 
 (b) The foregoing provision shall not impose on any First
Lien Agent or any other First Lien Creditor any obligations which would conflict with prior perfected claims therein in favor of any other Person or any order or decree of any court or other governmental authority or any applicable law or give rise
to risk of legal liability. 
 (c) Each of the First Lien Agents shall be entitled to rely, and shall be fully protected in relying, upon
any writing, communication, notice or other statement believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to Endologix),
independent accountants and other experts selected by such First Lien Agent. No First Lien Agent shall be liable for any action it takes or omits to take in good faith in reliance upon such writing, communication, notice or other statement. In
connection with any actions taken pursuant to this Agreement, each First Lien Agent shall also be entitled to all rights, protections, indemnities and immunities granted to it hereunder and under any other First Lien Loan Document. 

7. Representations and Warranties. 

7.1 Second Lien Creditors’ Representations and Warranties . Each Second Lien Creditor hereby
represents and warrants (as to itself and not as to any other Second Lien Creditor) to the First Lien Agents and the First Lien Creditors that as of the date hereof: 

(a) such Second Lien Creditor has the power and authority to enter into, execute, deliver, and carry out the terms of this
Agreement, all of which have been duly authorized by all proper and necessary action; 
 (b) the execution of this Agreement
by such Second Lien Creditor will not violate or conflict with the organizational documents of such Second Lien Creditor, the Second Lien Documents, or any law, regulation or order, or require any consent or approval that has not been obtained; and

 (c) this Agreement is the legal, valid, and binding obligation of such Second Lien Creditor, enforceable against such
Second Lien Creditor in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by
equitable principles. 
 7.2 First Lien Agent Representations and Warranties. Each First Lien Agent hereby represents
and warrants to the Second Lien Agent that as of the date hereof: 
 (a) such First Lien Agent has the power and authority to
enter into, execute, deliver, and carry out the terms of this Agreement, all of which have been duly authorized by all proper and necessary action; 

(b) the execution of this Agreement by such First Lien Agent will not violate or conflict with the organizational documents of
such First Lien Agent, the First Lien Loan Documents, or any law, regulation or order or require any consent or approval that has not been obtained; and 

  
 15 

 (c) this Agreement is the legal, valid, and binding obligation of such First
Lien Agent, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights
generally and by equitable principles. 
 8. Insolvency Proceedings. 

8.1 Subordination Agreement. This Agreement, which the parties hereto expressly acknowledge is a “subordination
agreement” under Section 510(a) of the Bankruptcy Code, shall be effective before, during and after the commencement of any Insolvency Proceeding. All references in this Agreement to Endologix or any Grantor shall include Endologix or such
Grantor as a debtor-in-possession and any receiver or trustee for Endologix or such Grantor in any Insolvency Proceeding. 

8.2 Liquidation, Dissolution, Bankruptcy. In the event of any Insolvency Proceeding involving Endologix or any other
Grantor: 
 (a) All First Lien Obligations shall first be Paid in Full and all commitments to lend under each First Lien
Credit Agreement shall be terminated before any Distribution, whether in cash, securities, or other property, shall be made to the Second Lien Agent or any other Second Lien Creditor on account of any Second Lien Obligations. 

(b) Any Distribution, whether in cash, securities or other property which would otherwise, but for the terms hereof, be payable
or deliverable in respect of the Second Lien Obligations shall be delivered to the First Lien Agents, and applied in accordance with the terms of the First Lien Loan Documents. Each of the Second Lien Agent and each other Second Lien Creditor
irrevocably authorizes, empowers and directs any debtor, debtor-in-possession, receiver, trustee, liquidator, custodian or conservator, or other Person having authority,
to pay or otherwise deliver all such Distributions to the First Lien Agents as set forth above. Each of the Second Lien Agent and each other Second Lien Creditor also irrevocably authorizes and empowers each First Lien Agent, in the name of the
Second Lien Agent, to demand, sue for, collect and receive any and all such Distributions. 
 (c) Each of the Second Lien
Agent and each other Second Lien Creditor agrees not to initiate, prosecute or participate in any claim, action or other proceeding challenging the enforceability, validity, perfection or priority of any portion of the First Lien Obligations or any
Liens and security interests securing any portion of the First Lien Obligations. 
 (d) Each of the Second Lien Agent and
each other Second Lien Creditor, agrees that the First Lien Creditors may consent to the use of cash collateral or provide (or consent to a third party providing)
debtor-in-possession financing to Endologix or the other Grantors on such terms and conditions and in such amounts as the First Lien Creditors, in their sole discretion,
may decide and, in connection therewith, Endologix and any other Grantor may grant to the First Lien Agents liens and security interests upon all of the property of Endologix or such Grantor, which liens and security interests (i) shall secure
payment of all First Lien Obligations owing to the First Lien Creditors (whether such First Lien Obligations arose prior to the commencement of any Insolvency Proceeding or at any time thereafter) and all other financing provided by the First Lien
Creditors during such Insolvency Proceeding and (ii) shall be superior in priority to the Liens in favor of the Second Lien Agent and the Second Lien Creditors, if any. Each of the Second Lien Agent and each other Second Lien Creditor, agrees
that it will not object to or oppose, and hereby affirmatively consents to and approves, any such cash collateral usage or debtor-in-possession financing or any sale or
other disposition of any property securing all of any part of the First Lien Obligations free and clear 

  
 16 

 
of security interests, liens, or other claims of any Second Lien Creditor under Section 363 of the Bankruptcy Code or any other provision of the Bankruptcy Code, if the First Lien Creditors
have consented to such sale or disposition. Each of the Second Lien Agent and each other Second Lien Creditor, agrees not to assert any right it may have to “adequate protection” of its interest in any Collateral in any Insolvency
Proceeding and agrees that it will not seek to have the automatic stay lifted with respect to any Collateral without the prior written consent of each First Lien Agent; provided that, such First Lien Agent will not object to any request by
the Second Lien Agent for adequate protection replacement liens on all prepetition and postpetition property of Endologix upon which such First Lien Agent is also granted adequate protection replacement liens, with such liens in favor of the Second
Lien Agent being subject in all respects to this Agreement; provided, further that, other than such replacement liens, the Second Lien Agent will not seek any other form of adequate protection. Each of the Second Lien Creditors waives any
claim it may now or hereafter have against any First Lien Creditor arising out of the election of any First Lien Creditor of the application of Section 1111(b)(2) of the Bankruptcy Code or out of any cash collateral or financing arrangement or
out of any grant of a security interest in connection with the Collateral in any Insolvency Proceeding. Each of the Second Lien Creditors agrees that it will not provide, or offer to provide, any debtor-in-possession financing to Endologix or any other Grantor without the prior written consent of each First Lien Agent. The Second Lien Creditor further agrees that it will not seek to participate on any
creditor’s committee without the prior written consent of the First Lien Agents. 
 (e) The Second Lien Agent, on behalf
of itself and the other Second Lien Creditors, agrees to execute, verify, deliver and file any proofs of claim in respect of the Second Lien Obligations reasonably requested by any First Lien Agent in connection with any such Insolvency Proceeding
and hereby irrevocably authorizes such First Lien Agent as its agent and attorney-in-fact to (i) execute, verify, delivery and file such proofs of claim upon the
failure of the Second Lien Agent to do so prior to ten (10) Business Days before the expiration of the time to file any such proof of claim and (ii) vote such claim in any such Insolvency Proceeding upon the failure of the Second Lien
Agent or any Second Lien Creditor to do so prior to ten (10) days before the expiration of time to vote any such claim (for such voting purposes, the First Lien Agent shall be deemed to have subrogated to any rights of the Second Lien Creditors
in respect of their claims in such Insolvency Proceeding); provided, however, that neither the First Lien Agents nor any First Lien Creditor shall have any obligation to execute, verify, deliver, and/or file any such claim; provided
further, that if the Second Lien Agent or any Second Lien Creditor votes its claim, it shall not vote for any plan of reorganization that does not provide for the prior payment in full of the First Lien Obligations on the date of confirmation or
effectiveness or otherwise vote its claims or interests in any Insolvency Proceeding (including voting for, or supporting, confirmation of any plan of reorganization) in a manner that would be inconsistent with such Second Lien Creditor’s
covenants and agreements contained herein. For the avoidance of doubt, no First Lien Agent shall have an affirmative obligation to file any such proof of claim on behalf of any Second Lien Creditor. In the event that any First Lien Agent votes any
claim in accordance with the authority granted hereby, neither any Second Lien Creditor nor the Second Lien Agent shall be entitled to change or withdraw such vote. 

(f) Each Second Lien Creditors hereby appoint each First Lien Agent (or its designee) as its authorized agent and
representative for purposes of taking any and all actions in any Insolvency Proceedings on the behalf of the Second Lien Creditors, including for purposes of voting such Second Lien Creditor’s claims in any such proceedings; and each Second
Lien Creditor hereby agrees and acknowledges that the foregoing appointment and authorization are intended to be enforceable for all purposes under applicable law, including 

  
 17 

 
Section 1126(a) of the United States Bankruptcy Code, and, in furtherance, due to, among other things, the requirement hereunder that during any such Insolvency Proceedings all First Lien
Obligations be Paid in Full prior to any Distribution in respect of the Second Lien Obligations being permitted hereunder, any vote by any such authorized agent or representative shall be deemed conclusively, for all purposes, to have been
consistent with, and in furtherance of, the interests of each Second Lien Creditor. 
 (g) The First Lien Obligations shall
continue to be treated as First Lien Obligations and the provisions of this Agreement shall continue to govern the relative rights and priorities of the First Lien Creditors and the Second Lien Creditors even if all or part of the First Lien
Obligations or the Liens or security interests securing the First Lien Obligations are subordinated, set aside, avoided, invalidated or disallowed in connection with any such Insolvency Proceeding. This Agreement shall be reinstated if at any time
any payment of any of the First Lien Obligations is rescinded or must otherwise be returned by any holder of First Lien Obligations or any representative of such holder. 

(h) Each of Endologix, each First Lien Agent, the Second Lien Agent and each other Second Lien Creditor acknowledges and agrees
with respect to the Collateral that (i) the grants of Liens on the Collateral pursuant to the First Lien Loan Documents and the Second Lien Documents constitute separate and distinct grants of Liens, and (ii) because of, among other
things, their differing rights in the Collateral, the First Lien Obligations and the Second Lien Obligations are fundamentally different from one another and must be separately classified in any plan of reorganization proposed or adopted in an
Insolvency Proceeding of Endologix. To further effectuate the intent of the parties as provided in the immediately preceding sentence, if it is determined by a court of competent jurisdiction that the claims of the First Lien Creditors and the
Second Lien Creditors in respect of any Collateral, constitute only one secured claim (rather than separate classes of senior and junior secured claims), then the First Lien Creditors shall be entitled to receive, in addition to amounts distributed
to them from, or in respect of, the Collateral in respect of principal, prepetition interest, fees, costs, expenses and other claims, all amounts owing in respect of postpetition interest, fees, costs, expenses and other charges, irrespective of
whether a claim for such amounts is allowed or allowable in such liquidation or Insolvency Proceeding, before any Distribution from, or in respect of, any such Collateral is made in respect of the claims held by any Second Lien Creditor. The Second
Lien Agent, on behalf of itself and the other Second Lien Creditors, hereby agrees to turn over to the First Lien Agents amounts otherwise received or receivable by it to the extent necessary to effectuate the intent of the preceding sentence,
regardless of whether such turnover has the effect of reducing the claim or recovery of any Second Lien Creditor. 
 9. Miscellaneous.

 9.1 Conflict. In the event of any conflict between any term, covenant, or condition of this Agreement and any term,
covenant, or condition of the Second Lien Documents, the provisions of this Agreement shall control and govern. 
 9.2
Continuing Subordination; Termination of Agreement. This is a continuing agreement of subordination and the First Lien Creditors may continue, at any time and without notice to the Second Lien Creditors, to extend credit or other financial
accommodations and loan monies to, or for the benefit of, Endologix on the faith hereof. This Agreement shall remain in full force and effect until the First Lien Obligations have been Paid in Full, after which this Agreement shall terminate without
further action on the part of the parties hereto. 

  
 18 

 9.3 Amendments; Modifications. This Agreement constitutes the entire
agreement and understanding of the parties relating to the subject matter hereof and supersedes all prior and contemporaneous agreements and understandings, whether oral or written, relating to the subject matter hereof. Any modification or waiver
of any provision of this Agreement, or any consent to any departure by any party from the terms hereof, shall not be effective in any event unless the same is in writing and signed by each First Lien Agent and the Second Lien Agent, and then such
modification, waiver, or consent shall be effective only in the specific instance and for the specific purpose given. Any notice to or demand on any party hereto in any event not specifically required hereunder shall not entitle the party receiving
such notice or demand to any other or further notice or demand in the same, similar or other circumstances unless specifically required hereunder. Notwithstanding anything contained in this Agreement to the contrary, the relative rights and
obligations of the Facility Agent, on the one hand, and the ABL Agent, on the other hand, solely as among themselves, shall be governed by the terms of the Intercreditor Agreement. 

9.4 No Subrogation. No Second Lien Creditor shall be subrogated to the rights of the First Lien Agents with respect to
receipt of Distributions on account of the Second Lien Obligations unless and until all of the First Lien Obligations have been Paid in Full. For the purposes of such subrogation, no Distributions made to the holders of the First Lien Obligations to
which any Second Lien Creditor would be entitled except for this Agreement, and no payments made pursuant to the provisions of this Agreement to any First Lien Agent or any other First Lien Creditor by such Second Lien Creditor shall, as among
Endologix, its creditors and such Second Lien Creditor, be deemed to be a payment by Endologix to or on account of the Second Lien Obligations. The Second Lien Agent, on behalf of itself and the other Second Lien Creditors, agrees that in the event
that all or any part of a payment made with respect to the First Lien Obligations is recovered from the holders of the First Lien Obligations in an Insolvency Proceeding or otherwise, any Distribution received by the Second Lien Agent or any other
Second Lien Creditor with respect to the Second Lien Obligations at any time after the date of the payment that is so recovered, whether pursuant to the right of subrogation provided for in this Agreement or otherwise, shall be deemed to have been
received by such Second Lien Creditor in trust as property of the holders of the First Lien Obligations, and such Second Lien Creditor shall forthwith deliver the same to the First Lien Agents for application to the First Lien Obligations, until the
First Lien Obligations have been Paid in Full. 
 9.5 No impairment. No right of the First Lien Creditors to enforce
the provisions hereof shall at any time in any way be prejudiced or impaired by any act taken in good faith, or failure to act, which failure to act is in good faith, by the First Lien Creditors or by any
non-compliance by Endologix with the terms and provisions and covenants herein. Each of the Second Lien Agent, each other Second Lien Creditor and Endologix agree not to take any action to avoid or to seek to
avoid the observance and performance of the terms and conditions hereof, and shall at all times in good faith carry out all such terms and conditions. 

9.6 Second Lien Obligations Not Affected. The subordination provisions of this Agreement are and are intended solely for
the purposes of defining the relative rights of the Second Lien Creditors, on the one hand, and the First Lien Creditors, on the other hand, as among themselves. Subject to this Agreement, as between Endologix and the Second Lien Agent, nothing
contained herein shall impair the unconditional and absolute obligation of Endologix to the Second Lien Agent to pay the Second Lien Obligations as they become due and payable. No Person other than the First Lien Creditors and the Second Lien
Creditors and their respective successors and assigns shall have any rights hereunder. 
 9.7 Successors and Assigns.
This Agreement shall inure to the benefit of, and shall be binding upon, the respective successors and assigns of the First Lien Creditors, the Second Lien Creditors and Endologix. To the extent permitted under the First Lien Loan Documents, the
First 

  
 19 

 
Lien Creditors may, from time to time, without notice to the Second Lien Agent, assign or transfer any or all of the First Lien Obligations or any interest therein to any Person and,
notwithstanding any such assignment or transfer, or any subsequent assignment or transfer, the First Lien Obligations shall, subject to the terms hereof, be and remain First Lien Obligations for purposes of this Agreement, and every permitted
assignee or transferee of any of the First Lien Obligations or of any interest therein shall, to the extent of the interest of such permitted assignee or transferee in the First Lien Obligations, be entitled to rely upon and be the third party
beneficiary of the subordination provided under this Agreement and shall be entitled to enforce the terms and provisions hereof to the same extent as if such assignee or transferee were initially a party hereto. Each Second Lien Creditor further
acknowledges that this Agreement will inure to the benefit of any third Person who refinances or succeeds to or replaces any or all of the First Lien Obligations, whether such successor financing or replacement occurs by transfer, assignment or
repayment, without the necessity of any further writing; provided, however, each Second Lien Creditor agrees, upon the request of such third Person, to execute and deliver an agreement with such Person containing terms substantially identical
to those contained herein (subject to changing names of parties, documents and addresses, as appropriate). 
 9.8 First
Lien Creditors’ Rights and Remedies. The rights, remedies, powers and privileges of each First Lien Creditor hereunder (hereinafter, the “First Lien Creditors’ Rights and Remedies”) shall be cumulative and not
exclusive of any rights or remedies which it would otherwise have. No delay or omission by any First Lien Creditor in exercising or enforcing any of the First Lien Creditors’ Rights and Remedies shall operate as, or constitute, a waiver
thereof. No waiver by any First Lien Creditor of any of the First Lien Creditors’ Rights and Remedies or of any default or remedy under this Agreement or any other agreement with Endologix or any Second Lien Creditor shall operate as a waiver
of any other default hereunder or thereunder. No exercise of the First Lien Creditors’ Rights and Remedies and no other agreement or transaction, of whatever nature, entered into between any First Lien Creditor and the Second Lien Creditors
and/or between any First Lien Creditor and Endologix at any time shall preclude any other or further exercise of the First Lien Creditors’ Rights and Remedies. No waiver by any First Lien Senior Creditor of any of the First Lien Creditors’
Rights and Remedies on any one occasion shall be deemed a continuing waiver. All of the First Lien Creditors’ Rights and Remedies and all of the First Lien Creditors’ rights, remedies, powers and privileges under this Agreement and any
other agreement with the Second Lien Creditors and/or Endologix shall be cumulative, and not alternative or exclusive, and may be exercised by the First Lien Creditors at such time or times and in such order of preference as the First Lien Creditors
in their sole discretion may determine. 
 9.9 Notices. 

(a) Unless otherwise specifically provided herein, any notice hereunder shall be in writing and may be personally served, or
sent by electronic mail or United States mail or courier service and shall be deemed to have been given when delivered in person or by courier service and signed for against receipt thereof, upon receipt of electronic mail, or three business days
after depositing it in the United States mail with postage prepaid and properly addressed (or one business day after depositing with an overnight mail service). For the purposes hereof, the addresses of the parties hereto shall be as set forth, or
at such other address as may be designated by such party in a written notice to all of the other parties: 
 (i) if to the
Facility Agent, to: 
 c/o Deerfield Management Company, L.P. 

780 Third Avenue, 37th Floor 

New York, NY 10017 

  
 20 

 E-mail: dclark@deerfield.com 

Attn: David J. Clark, Esq. 

With a copy to (which shall not be deemed to constitute notice): 

Katten Muchin Rosenman LLP 

575 Madison Avenue 

New York, NY 10022-2585 

E-mail: mark.ramsey@katten.com 

E-mail: mark.wood@katten.com 

Attn: Mark P. Ramsey, Esq. 

Attn: Mark Wood, Esq. 

(ii) if to ABL Agent: 

c/o Deerfield Management Company, L.P. 

780 Third Avenue, 37th Floor 

New York, NY 10017 

E-mail: dclark@deerfield.com 

Attn: David J. Clark, Esq. 

With a copy to (which shall not be deemed to constitute notice): 

Katten Muchin Rosenman LLP 

575 Madison Avenue 

New York, NY 10022-2585 

E-mail: mark.ramsey@katten.com 

E-mail: mark.wood@katten.com 

Attn: Mark P. Ramsey, Esq. 

Attn: Mark Wood, Esq. 

(iii) if to Second Lien Agent, the Trustee or to any Second Lien Creditor, to: 

Wilmington Trust, National Association 

50 South Sixth Street, Suite 1290 

Minneapolis, MN 55402 

Attn: Endologix, Inc., Account Manager 

(iv) if to Endologix or any other Grantor, to: 

Endologix, Inc. 

2 Musick 

Irvine, CA 92618 

E-mail: vmahboob@endologix.com 

E-mail: jtejedor@endologix.com 

Attn: Vaseem Mahboob, CFO 

Attn: James Tejedor, Treasury Manager 

With a copy to (which shall not be deemed to constitute notice): 

DLA Piper LLP (US) 

  
 21 

 444 West Lake Street, Suite 900 

Chicago, IL 60606 

E-mail: gregory.ruback@dlapiper.com 

Attn: Gregory Ruback 

(b) Each party hereto may, in its discretion, agree to accept notices and other communications to it hereunder by electronic
communications pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications. 

(c) Any party hereto may change its address or facsimile number for notices and other communications hereunder by notice to the
other parties hereto. 
 9.10 Further Assurances. Each party to this Agreement will promptly execute and deliver such
further instruments and agreements and do such further acts and things as may be reasonably requested in writing by any other party hereto that may be necessary or desirable in order to effect fully the purposes of this Agreement. 

9.11 Headings. The section headings used in this Agreement are for convenience only and shall not affect the
interpretation of any of the provisions hereof. 
 9.12 Counterparts; Integration; Effectiveness; Electronic
Execution. This Agreement and any amendments, waivers, consents or supplements hereto may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all taken together
shall constitute a single contract. This Agreement constitutes the entire contract among the parties with respect to the subject matter hereof and supersedes all previous agreements and understandings, oral or written, with respect thereto. This
Agreement shall become effective when it shall have been executed by each First Lien Agent, the Second Lien Agent, each Second Lien Note Holder and Endologix and when the First Lien Agents shall have received counterparts hereof that together bear
the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or in electronic (i.e., “pdf” or “tif”) format shall be effective as delivery of a
manually executed counterpart of this Agreement. 
 9.13 Severability. In the event that any provision of this
Agreement is deemed to be invalid, illegal or unenforceable by reason of the operation of any law or by reason of the interpretation placed thereon by any court or governmental authority, the validity, legality, and enforceability of the remaining
provisions of this Agreement shall not in any way be affected or impaired thereby, and the affected provision shall be modified to the minimum extent permitted by law so as to most fully achieve the intention of this Agreement. 

9.14 Specific Performance. The First Lien Creditors may demand specific performance of this Agreement. The Second Lien
Creditors and Endologix each hereby irrevocably waive any defense based on the adequacy of a remedy at law and any other defense which might be asserted to bar the remedy of specific performance in any action which may be brought by any First Lien
Creditor. 
 9.15 Expenses. In the event that the First Lien Creditors or Second Lien Creditors undertake any action
that is reasonably necessary in respect of the enforcement of the provisions of this Agreement (whether or not suit is commenced), Endologix shall pay all reasonable costs and expenses incurred by the First Lien Creditors or Second Lien Creditors in
connection therewith, including, reasonable attorneys’ fees all in accordance with the First Lien Loan Documents and Second Lien Documents. 

  
 22 

 9.16 Second Lien Default Notice. Upon the occurrence of a Second Lien
Event of Default, Endologix shall provide the First Lien Agents with written notice of each Second Lien Event Default, and the Second Lien Agent shall notify the First Lien Agents in the event such Second Lien Event of Default is cured or waived.

 9.17 Governing Law; Jurisdiction; Etc.

(a) THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND
ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK
GENERAL OBLIGATIONS LAW) THEREOF. 
 (b) ALL JUDICIAL PROCEEDINGS BROUGHT AGAINST ANY PARTY OR GRANTOR ARISING OUT OF OR
RELATING HERETO MAY BE BROUGHT IN ANY STATE OR FEDERAL COURT OF COMPETENT JURISDICTION IN THE STATE, COUNTY AND CITY OF NEW YORK (INCLUDING, WITHOUT LIMITATION, THE COMMERCIAL DIVISION, NEW YORK STATE SUPREME COURT). BY EXECUTING AND DELIVERING THIS
AGREEMENT, EACH PARTY (AND EACH GRANTOR BY ACKOWLEDGING AND AGREEING TO THIS AGREEMENT), FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, IRREVOCABLY: 

(i) ACCEPTS GENERALLY AND UNCONDITIONALLY THE NONEXCLUSIVE JURISDICTION AND VENUE OF SUCH COURTS; 

(ii) WAIVES ANY DEFENSE OF FORUM NON CONVENIENS; 

(iii) AGREES THAT SERVICE OF ALL PROCESS IN ANY SUCH PROCEEDING IN ANY SUCH COURT MAY BE MADE BY REGISTERED OR CERTIFIED MAIL,
RETURN RECEIPT REQUESTED, TO THE APPLICABLE PARTY AT ITS ADDRESS PROVIDED IN ACCORDANCE WITH SECTION 9.9; AND 
 (iv) AGREES
THAT SERVICE AS PROVIDED IN CLAUSE (iii) ABOVE IS SUFFICIENT TO CONFER PERSONAL JURISDICTION OVER THE APPLICABLE PARTY IN ANY SUCH PROCEEDING IN ANY SUCH COURT, AND OTHERWISE CONSTITUTES EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT. 

9.18 Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY. EACH PARTY HERETO (A) CERTIFIES
THAT NO AGENT, ATTORNEY, REPRESENTATIVE OR ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF LITIGATION, AND (B) ACKNOWLEDGES THAT IT AND THE OTHER
PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 

  
 23 

 9.19 It is understood and agreed that Wilmington Trust, National Association
is entering in this Agreement in its capacity as “Collateral Agent” under the Second Lien Documents and the rights, powers, privileges, protections, immunities and benefits afforded to the “Collateral Agent” under the Second Lien
Documents shall also apply to Wilmington Trust, National Association, as the Second Lien Agent hereunder, and the holders of the Notes have expressly authorized and instructed the Second Lien Agent to execute and deliver this Agreement. In addition,
but not in substitution of the foregoing and except as expressly provided in this Agreement, (A) the Second Lien Agent shall not be subject to any fiduciary, trust or other implied duties to the First Lien Agents or First Lien Creditors by
reason of this Agreement and (B) no First Lien Agent shall be subject to any fiduciary, trust or other implied duties to the Second Lien Agent or the other Second Lien Creditors by reason of this Agreement. For the avoidance of doubt, the
Second Lien Noteholders and not the Second Lien Agent shall be the only Persons entitled to exercise any remedies under the Exchange Agreement, it being understood that the Second Lien Agent shall have no responsibility therefor. 

[SIGNATURE PAGE FOLLOWS] 

  
 24 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written. 

 

			
	DEERFIELD PRIVATE DESIGN FUND IV, L.P., as Facility Agent

 
			
		
	By	 	 /s/ David J. Clark

			
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	DEERFIELD ELGX REVOLVER, LLC, as ABL Agent

 
			
		
	By	 	 /s/ David J. Clark

			
	Name:	 	David J. Clark
	Title:	 	Authorized Signatory
	
	WILMINGTON TRUST, NATIONAL ASSOCIATION, as Second Lien Agent

 
			
		
	By	 	  

 
			
	Name:	 	
	Title:	 	
	
	[SECOND LIEN CREDITOR], as a Second Lien Creditor

 
			
		
	By	 	  

 
			
	Name:	 	
	Title:	 	

  

			
	ENDOLOGIX, INC., a Delaware corporation

 
			
		
	By:	 	 /s/ Vaseem Mahboob

			
	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer

  
 25 

 ACKNOWLEDGMENT AND AGREEMENT 

Each of the undersigned hereby acknowledges and agrees as of February 24, 2020 to the representations, terms and provisions of the
Subordination and Intercreditor Agreement, dated as of the date hereof (the “Subordination Agreement”; capitalized terms used herein without definition shall have the meaning assigned thereto in the Subordination Agreement), by and
between Deerfield Private Design Fund IV, L.P., as Facility Agent, Deerfield ELGX Revolver, LLC, as ABL Agent, Wilmington Turst, National Association, as Second Lien Agent, and PCH Manager Manager Fund, SPC. – Segregated Portfolio 206, Corrib
Master Fund, Ltd., NPB Manager Manager Fund, SPC. – Segregated portfolio 107, Long Ball Partner, LLC, LMAP Kappa Limited (“Kappa”), Blackwell Partners-LLC_Series B (“MACK”) and Silverback Opportunistic Credit Master Fund
Limited (“SOCMF”), each as a Second Lien Creditor, of which this Acknowledgment and Agreement is a part. By its signature below, the undersigned agrees that it shall, together with its successors and assigns, be bound by the provisions
hereof that are applicable to it, that it shall not do any act or perform any obligation which is in contravention with the agreements set forth herein or in the Subordination Agreement and that it shall recognize all rights granted hereby to the
Facility Secured Parties, the ABL Secured Parties and the Second Lien Creditors . 
 Each of the undersigned acknowledges and agrees that,
(i) although it has signed this Acknowledgement and Agreement, it is not a party to the Subordination Agreement and does not and will not receive any right, benefit, priority or interest under or because of the existence of or adherence and
agreement to the Subordination Agreement, (ii) any breach by the undersigned of any of its obligations under the Subordination Agreement or this Acknowledgment and Agreement will constitute an Event of Default under the terms of each of the ABL
Agreement and the Facility Agreement, (iii) it will cause each future direct or indirect subsidiary of Endologix that is a Grantor with respect to the First Lien Obligations to execute and deliver an acknowledgment and agreement to this
Subordination Agreement in substantially the same form as this Acknowledgment and Agreement, and (iv) the terms of the Subordination Agreement shall not give any Grantor, nor modify any, substantive rights vis-à-vis any ABL Secured Party or any Facility Secured Party, nor modify any obligations or liabilities owing to such ABL Secured Party or such Facility Secured Party by such Grantor, under any
instrument, document, agreement or arrangement, and (x) as between the ABL Secured Parties and the Grantor, the ABL Documents remain in full force and effect as written and are in no way modified hereby, and (y) as between the Facility
Secured Parties and the Grantors, the Facility Documents remain in full force and effect as written and are in no way modified hereby and (z) as between the Second Lien Creditors and Endologix, the Second Lien Documents remain in full force and
effect as written and are in no way modified hereby. 
 [SIGNATURE PAGE FOLLOWS] 

  
 26 

									
	Acknowledged and agreed:	 		 		 	ENDOLOGIX, INC., a Delaware corporation
				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
				
		 		 		 	 CVD/RMS ACQUISITION CORP.,
 a
Delaware corporation

				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
				
		 		 		 	NELLIX, INC., a Delaware corporation
				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
			
		 		 	 TRIVASCULAR TECHNOLOGIES, INC.,
 a
Delaware corporation

			
		 		 	By: /s/ Vaseem
Mahboob                                        
                    
		 		 	Name: Vaseem Mahboob
		 		 	Title: Chief Financial Officer
				
		 		 		 	 TRIVASCULAR, INC., a California

corporation

				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
				
		 		 		 	 ENDOLOGIX CANADA, LLC,
 a Delaware
limited liability company

				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
				
		 		 		 	 TRIVASCULAR SALES LLC,
 a Texas
limited liability company

				
		 		 		 	By: /s/ Vaseem
Mahboob                                        

		 		 		 	Name: Vaseem Mahboob
		 		 		 	Title: Chief Financial Officer
				
		 		 		 	 RMS/ENDOLOGIX SIDEWAYS MERGER CORP.,

a Delaware corporation

  

  
 27 

 
			
	By: /s/ Vaseem
Mahboob                                        

	Name: Vaseem Mahboob
	Title: Chief Financial Officer

  
 28EX-10.5

 Exhibit 10.5 

Notwithstanding anything herein to the contrary, the liens and security interest granted to the Agent pursuant to or in connection with this Agreement or any
other Security Document, and the exercise of any right or remedy by the Agent or any other Secured Party hereunder or thereunder are subject to the provisions of the Subordination and Intercreditor Agreement dated as of February
[    ], 2020 (as amended, restated, supplemented or otherwise modified from time to time, the “Subordination and Intercreditor Agreement”), among Deerfield Private Design Fund IV, L.P., as Facility Agent,
Deerfield ELGX Revolver, LLC, as ABL Agent (the Facility Agent and the Facility Agent, the “First Lien Agents”), Wilmington Trust, National Association, as Second Lien Agent, the Noteholders party thereto, and Endologix, Inc. In the event
of any conflict between the terms of the Subordination and Intercreditor Agreement and this agreement or any Security Document, the terms of the Subordination and Intercreditor Agreement shall control. 

JUNIOR LIEN SECURITY AGREEMENT 

dated as of February [    ], 2020 

by and between 

Endologix, Inc., 
 as
Company 
 and 

WILMINGTON TRUST, NATIONAL ASSOCIATION, 

as Collateral Agent for itself and the other Secured Parties 

 JUNIOR LIEN SECURITY AGREEMENT 

This JUNIOR LIEN SECURITY AGREEMENT (this “Agreement”), dated as of February [     ], 2020, by and
between Endologix, Inc., a Delaware corporation (the “Company”) and Wilmington Trust, National Association, as Collateral Agent (the “Agent”). 

RECITALS 

Reference is made to that certain Indenture dated as of February [    ], 2020 , between the Company and Wilmington Trust,
National Association, as Trustee and Collateral Agent (as amended, waived, supplemented or otherwise modified from time to time, the “Indenture”). Pursuant to the Indenture, the Company has issued
$[                ] aggregate principal amount of 5.0% Voluntary Convertible Senior Secured Notes due 2024 (the “Notes”); 

WHEREAS, it is a condition precedent to the release of the funds constituting proceeds from issuance of the Notes that the Company shall have
executed and delivered this Agreement and all other applicable Security Documents (as defined below) to the Agent for the benefit of the Agent and the other Secured Parties (as defined below); 

WHEREAS, the Company has previously granted to (i) the Facility Agent (as defined below), for the benefit of the holders of the
obligations under the Facility Agreement (as defined below), a senior priority security interest in the Collateral and (ii) the ABL Agent (as defined below), for the benefit of the holders of obligations under the ABL Agreement (as defined
below), a senior priority security interest in the Collateral; 
 WHEREAS, the security interest granted by the Company hereunder to the
Agent is subject to the senior priority security interests of the Facility Agent and the ABL Agent; and 
 WHEREAS, the relative rights and
priorities of the grantees in respect of the Collateral are governed by the Subordination and Intercreditor Agreement, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the
“Subordination and Intercreditor Agreement”) a copy of which is annexed hereto as Exhibit A, among the Company, the Facility Agent, the ABL Agent, the Agent and the holders of the Notes. 

Accordingly, the parties hereto agree as follows: 

SECTION 1. DEFINITIONS. 
 1.1 Unless
otherwise defined herein, terms defined in the Indenture and used herein shall have the meanings given to them in the Indenture and the following terms are used herein as defined in the UCC (such meanings to be equally applicable to both the
singular and plural forms of the terms defined): “accounts”, “certificated security”, “chattel paper”, “commercial tort claims”, “commodity contract”, “deposit accounts”,
“documents”, “electronic chattel paper”, “equipment”, “farm products”, “fixture”, “general intangibles”, “goods”, “health care insurance receivables”,
“instruments”, “inventory”, “leases”, “letter-of-credit rights”, “money”, “payment intangibles”,
“product”, “record”, “securities account”, “security”, “supporting obligations”, and “tangible chattel paper”. It is hereby agreed that the term “instrument” shall not include
checks received in the ordinary course of business. 
 1.2 Whenever used in this Agreement, the Exhibits or the Schedules attached hereto,
unless the context otherwise requires, the following terms have the following meanings: 

 “ABL Agent” has the meaning assigned to such term in the Subordination and
Intercreditor Agreement. 
 “ABL Agreement” has the meaning assigned to such term in the Subordination and Intercreditor
Agreement. 
 “Agent” has the meaning set forth in the preamble of this Agreement. 

“Agreement” has the meaning set forth in the preamble of this Agreement. 

“Bank of America Cash Collateral Account” means that certain deposit account #******4066 of the Company at Bank of America,
N.A. (or such replacement deposit account provided by Bank of America, N.A. or by another commercial bank) established and maintained for the sole purpose of providing cash collateral in favor of Bank of America, N.A. (or such replacement commercial
bank) for obligations of the Company in respect of certain commercial credit cards provided to the Company by Bank of America, N.A. (or such replacement commercial bank); provided that the aggregate amount on deposit in such deposit
account (or such replacement deposit account) shall not at any time exceed $2,500,000. 
 “Closing Date” means February
[     ], 2020 or on such other date as the Company and Agent may agree in writing. 
 “Company” has the
meaning set forth in the preamble of this Agreement. 
 “Collateral” means all of the Company’s assets, whether now
owned or hereafter created, acquired or arising, including without limitation, all of the Company’s right, title and interest in and to the following: 

(a) all goods, accounts (including health care insurance receivables), equipment, inventory, contract rights or rights to
payment of money, leases, license agreements and other licenses, franchise agreements, general intangibles, commercial tort claims (including any Identified Claims), documents, instruments (including any promissory notes) (and any distribution of
property made on, in respect of or in exchange for such instruments from time to time), chattel paper (whether tangible chattel paper or electronic), cash, Cash Equivalents, deposit accounts, Intellectual Property, Intellectual Property Licenses,
securities accounts, fixtures, letter-of-credit rights (whether or not the letter of credit is evidenced by a writing), securities, all other Pledged Collateral and
Pledged Investment Property (including any distribution of property made on, in respect of or in exchange for such Pledged Collateral and/or Pledged Investment Property from time to time) and all supporting obligations related to any of the
foregoing, and financial assets, wherever located; 
 (b) all books and records relating to any of the foregoing; 

(c) all property of the Company held by any Secured Party, including all property of every description, in the custody of or in
transit to such Secured Party for any purpose, including safekeeping, collection or pledge, for the account of the Company or as to which the Company may have any right or power, including but not limited to cash; and 

(d) any and all claims, rights and interests in any of the above and all substitutions for, additions, attachments,
accessories, accessions and improvements to and replacements, products, Proceeds and insurance Proceeds of any or all of the foregoing. 

  
 3 

 Where the context requires, terms relating to the Collateral or any part thereof, when used in relation to
the Company, shall refer to the Company’s Collateral or the relevant part thereof. Notwithstanding the foregoing, “Collateral” shall not include Excluded Property; provided, however, that if and when any assets cease to
be Excluded Property, the term “Collateral” shall include such assets and a Lien on and security interest in such assets shall be deemed granted therein pursuant to Section 3.1 hereof. 

“Copyrights” means any and all rights in any works of authorship, including (A) copyrights and moral rights,
(B) copyright registrations and recordings thereof and all applications in connection therewith including those listed on Schedule 8, (C) income, license fees, royalties, damages, and payments now and hereafter due or payable under and with
respect thereto, including payments under all licenses entered into in connection therewith and damages and payments for past, present, or future infringements thereof, (D) the right to sue for past, present, and future infringements thereof,
and (E) all of the Company’s rights corresponding thereto throughout the world. 
 “Domestic Subsidiary”
means any Subsidiary incorporated, organized or otherwise formed under the laws of the United States, any state thereof or the District of Columbia. 

“Excluded Domestic Holdco” means a wholly-owned Domestic Subsidiary of the Company substantially all of the assets of
which consist of equity interests of Excluded Foreign Subsidiaries held directly or indirectly by such Subsidiary and which does not engage in any business, operations or activity other than that of a holding company, excluding for purposes of such
determination, Indebtedness of such Excluded Foreign Subsidiaries. 
 “Excluded Foreign Subsidiary” means any Foreign
Subsidiary which is a controlled foreign corporation (as defined in the Code) that has not guaranteed or pledged any of its assets to secure, or with respect to which there shall not have been pledged
two-thirds or more of the voting Stock to secure, any Indebtedness (other than the Obligations) of the Company. 

“Excluded Property” means, collectively: 

(a) voting shares of any (A) Excluded Foreign Subsidiary of the Company or (B) Excluded Domestic Holdco, in each
case, in excess of 65% of all of the issued and outstanding voting shares of equity interests of such subsidiary; 
 (b) any
lease, license, contract, property right or agreement as to which, if and to the extent that, and only for so long as, the grant of a security interest therein shall (1) constitute or result in a breach, termination or default under any such
lease, license, contract, property right or agreement or render it unenforceable, (2) be prohibited by any applicable law or (3) require the consent of any third party (in each case of clauses (1), (2) and (3), other than to the extent
that any such breach, termination, default, prohibition or requirement for consent would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC of any relevant jurisdiction or any other applicable Law), provided that such security interest shall attach immediately to each portion of such
lease, license, contract, property rights or agreement that does not result in any of the consequences specified above; 

(c) any “intent to use” trademark applications for which a statement of use has not been filed (but only until such
statement is filed); 
 (d) motor vehicles and other assets, in each instance, in which perfection of a security requires
notation on certificates of title with a value, individually, of less than $250,000; 

  
 4 

 (e) without in any way limiting clause (a) above, equity interests in
any Person (other than wholly owned Subsidiaries) to the extent not permitted by the terms of such Person’s organizational or joint venture documents; 

(f) any assets financed by purchase money indebtedness or capital leases, if the documentation governing such purchase money
indebtedness or capital leases prohibits the creation of a security interest or lien thereon or requires the consent of any Person as a condition to the creation of any other security interest or lien on such property or if such contract or other
agreement would be breached or give any party the right to terminate it as a result of creation of such security interest or lien; 

(g) any assets as to which either the Facility Agent or the ABL Agent does not have a prior perfected security interest; and

 (h) the Bank of America Cash Collateral Account; 

provided, however, notwithstanding anything to the contrary herein, “Excluded Property” shall not include any proceeds,
products, substitutions, receivables or replacements of Excluded Property (unless such proceeds, products, substitutions, receivables or replacements would otherwise constitute Excluded Property). 

“Facility Agent” has the meaning assigned to such term in the Subordination and Intercreditor Agreement. 

“Facility Agreement” has the meaning assigned to such term in the Subordination and Intercreditor Agreement. 

“Foreign Subsidiary” means, with respect to any Person, a Subsidiary of such Person, which Subsidiary is not a Domestic
Subsidiary. 
 “Fraudulent Transfer Laws” has the meaning set forth in Section 2.6 hereof. 

“Identified Claims” means the commercial tort claims described on Schedule 5, as such schedule shall be supplemented
from time to time in accordance with the terms and conditions of this Agreement. 
 “Indenture” has the meaning assigned to
such term in the preliminary statement of this Agreement. 
 “Intellectual Property License” means, with respect to the
Company (the “Specified Party”), (A) any licenses or other similar rights provided to the Specified Party in or with respect to Intellectual Property owned or controlled by any other Person, and (B) any licenses or other
similar rights provided to any other Person in or with respect to Intellectual Property owned or controlled by the Specified Party, in each case, including (1) any software license agreements, (2) the license agreements listed on
Schedule 9, and (3) the right to use any of the licenses or other similar rights described in this definition in connection with the enforcement of the Agent’s rights under the Security Documents. 

“Intellectual Property Security Agreements” means the short-form Patent Security Agreement, short-form Trademark Security
Agreement, and short-form Copyright Security Agreement, each substantially in the form reasonably agreed to by the Agent. 

  
 5 

 “Issuers” means the collective reference to each issuer of Pledged
Collateral and Pledged Investment Property. 
 “Lien” means any lien, pledge, preferential arrangement, mortgage, security
interest, deed of trust, charge, assignment, hypothecation, title retention or other encumbrance on or with respect to property or interest in property having the practical effect of constituting a security interest, in each case with respect to the
payment of any obligation with, or from the proceeds of, any asset or revenue of any kind. 
 “Paid in Full” and
“Payment in Full” each means with respect to Secured Obligations, all Secured Obligations have been repaid in full in cash (other than any unasserted contingent indemnification obligations); provided that the foregoing shall
be subject to any reinstatement pursuant to (and the other provisions set forth in) Section 8.18). 

“Patents” means patents and patent applications, including (A) the patents and patent applications listed on Schedule
10, (B) all continuations, divisionals, continuations-in-part, re-examinations, reissues, and renewals thereof and improvements
thereon, (C) all income, royalties, damages and payments now and hereafter due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and damages and payments for past, present, or
future infringements thereof, (D) the right to sue for past, present, and future infringements thereof, and (E) all of the Company’s rights corresponding thereto throughout the world. 

“Person” means and includes any natural person, individual, partnership, joint venture, corporation, trust, limited liability
company, limited liability partnership, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity. 

“Pledged Collateral” means, collectively, the Pledged Equity and the Pledged Debt Instruments. 

“Pledged Debt Instruments” means all right, title and interest of the Company in instruments evidencing any Indebtedness owed
to the Company or other obligations owed to the Company, including all Indebtedness described on Schedule 1, issued by the obligors named therein. Pledged Debt Instruments excludes any Excluded Property. 

“Pledged Equity” means collectively, all Pledged Interests and Pledged Stock. 

“Pledged Interests” shall mean, with respect to each limited liability company, partnership or other organization listed on
Schedule 1, (i) the Stock in such limited liability company, partnership or other organization owned by the Company and listed on Schedule 1, and the certificates, if any, representing such interests and any interest of the Company, as
applicable, on the books and records of such limited liability company, partnership or other organization or on the books and records of any securities intermediary pertaining to such interests, (ii) the Stock of any other Person whose Stock is
at any time hereafter issued or granted to, or held by the Company, and (iii) all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or Proceeds from time to time received, receivable or
otherwise distributed in respect of or in exchange for any or all interests set forth in the preceding clauses (i) and (ii). Pledged Interests excludes any Excluded Property. 

“Pledged Investment Property” means the collective reference to (i) all “investment property” as such term is
defined in Section 9-102(a)(49) of the UCC and (ii) all “financial assets” as such term is defined in Section 8-102(a)(9) of the UCC, other than
any Pledged Equity or Pledged Debt Instruments. Pledged Investment Property excludes any Excluded Property. 

  
 6 

 “Pledged Stock” shall mean, with respect to each corporation listed on
Schedule 1, the Stock of such corporation owned by the Company and listed on Schedule 1, and the certificates, if any, representing such shares and any interest of the Company, as applicable, in the entries on the books of the issuer
of such shares or on the books of any securities intermediary pertaining to such shares and the Stock of any other Person whose Stock is at any time hereafter issued to or granted to or held by the Company, and all dividends, distributions, cash,
warrants, rights, options, instruments, securities and other property or Proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such shares. Pledged Stock excludes any Excluded
Property. 
 “Proceeds” means all “proceeds” as such term is defined in
Section 9-102(a)(64) of the UCC and, in any event, shall include all dividends or other income from the Pledged Investment Property, collections thereon or distributions or payments with respect thereto.

 “Receivable” means any right to payment for goods sold or leased or for services rendered, whether or not such right is
evidenced by an instrument or chattel paper and whether or not it has been earned by performance (including any accounts). 

“Secured Obligations” means any principal, premium, interest (including any interest and fees accruing subsequent to the
filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest or fees is an allowed or allowable claim under applicable law), penalties,
fees, indemnifications, reimbursements, damages and other liabilities, and guarantees of payment of such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under any of the Indenture, the
Notes and the Security Documents. 
 “Secured Parties” means, collectively, the Agent, the Trustee, the Holders of Notes
and the other holders of Secured Obligations. 
 “Security Documents” means this Agreement, the Intellectual Property
Security Agreements and the security agreements, mortgages, pledge agreements, agency agreements and other instruments and documents executed and delivered pursuant to this Agreement or any of the foregoing, as the same may be amended, supplemented
or otherwise modified from time to time and pursuant to which Collateral is pledged, assigned or granted to or on behalf of the Agent for the benefit of the Secured Parties or notice of such pledge, assignment or grant is given. 

“Subordination and Intercreditor Agreement” has the meaning set forth in the recitals to this Agreement. 

“Subsidiary” or “Subsidiaries” means, with respect to any Person, (a) any corporation of which an
aggregate of more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or
classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with
respect to which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company
in which such Person and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a general
partner or may exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of the Company. 

  
 7 

 “Third Party Payor Programs” means all private or governmental programs
providing health care benefits, whether through insurance or otherwise, that are sponsored by a Third Party Payor. 

“Trademarks” means any and all trademarks, trade names, registered trademarks, trademark applications, service marks,
registered service marks and service mark applications, including (A) the trade names, registered trademarks, trademark applications, registered service marks and service mark applications listed on Schedule 11, (B) all renewals thereof,
(C) all income, royalties, damages and payments now and hereafter due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and damages and payments for past or future
infringements or dilutions thereof, (D) the right to sue for past, present and future infringements and dilutions thereof, (E) the goodwill of the Company’s business symbolized by the foregoing or connected therewith, and (F) all
of the Company’s rights corresponding thereto throughout the world. 
 “UCC” means the Uniform Commercial Code of any
applicable jurisdiction and, if the applicable jurisdiction shall not have any Uniform Commercial Code, the Uniform Commercial Code as in effect from time to time in the State of New York. 

SECTION 2. [RESERVED]. 
 SECTION 3. GRANT OF
SECURITY INTEREST. 
 3.1 Grant. The Company hereby collaterally assigns and grants to Agent, for the benefit of the Secured Parties,
a Lien on and security interest in all of its Collateral, as collateral security for the prompt and complete payment and performance when due (whether at the stated maturity, by acceleration or otherwise) of the Secured Obligations. Notwithstanding
the foregoing, no Lien or security interest is hereby granted on any Excluded Property. 
 3.2 Company Remains Liable. Anything herein to the
contrary notwithstanding, (i) the Company shall remain liable under any contracts, agreements and other documents included in the Collateral, to the extent set forth therein, to perform all of its duties and obligations thereunder to the same
extent as if this Agreement had not been executed, (ii) the exercise by the Agent of any of the rights hereunder shall not release the Company from any of its duties or obligations under such contracts, agreements and other documents included
in the Collateral, and (iii) neither the Agent nor any other Secured Party shall have any obligation or liability under any contracts, agreements and other documents included in the Collateral by reason of this Agreement, nor shall the Agent or
any other Secured Party be obligated to perform any of the obligations or duties of the Company thereunder or to take any action to collect or enforce any such contract, agreement or other document included in the Collateral hereunder. 

SECTION 4. REPRESENTATIONS AND WARRANTIES. 

The Company hereby represents and warrants to Agent and the other Secured Parties that the following are true, correct and complete, in each
case to the extent and in the manner set forth herein, on the Closing Date: 
 4.1 Title; No Other Liens. The Company (i) is the
record and beneficial owner of the Collateral pledged by it hereunder constituting instruments or certificates and (ii) has rights in or the power to transfer each other item of Collateral in which a Lien is granted by it hereunder. 

4.2 Valid Liens. The security interests granted in the Collateral pursuant to this Agreement constitute a valid and continuing perfected
security interest in all of the Company’ rights in the Collateral in favor of Agent as collateral security for the Secured Obligations, enforceable in accordance with the terms hereof, 

  
 8 

 
except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally upon (A) in the case
of all Collateral in which a security interest may be perfected by filing a financing statement under the UCC, completion of the filings and payment of related fees and expenses and the other actions specified on Schedule 2 (which filings and other
documents referred to on Schedule 2 have been delivered to Agent in completed form), (B) with respect to any deposit account or securities account, the execution of control agreements, and (C) in the case of all Copyrights, Trademarks and Patents
for which UCC filings are insufficient, all appropriate filings having been made with the applicable Intellectual Property registries, including but not limited to the United States Copyright Office or the United States Patent and Trademark Office,
as applicable. 
 4.3 Company Information. On the Closing Date, Schedule 3 sets forth (i) the Company’s jurisdiction
of organization, (ii) the location of the Company’s chief executive office, (iii) the Company’s exact legal name as it appears on its organizational documents and (iv) the Company’s organizational identification number
(to the extent the Company is organized in a jurisdiction which assigns such numbers) and federal employer identification number. 
 4.4
Collateral Locations. On the Closing Date, Schedule 4 sets forth (i) each place of business of the Company (including its chief executive office), (ii) all locations where any material portion of inventory and equipment owned by
the Company is kept (other than (A) inventory or equipment that is otherwise in transit or out for repair, refurbishment or processing in the Ordinary Course of Business, (B) de minimis amounts of inventory with sales personnel and at
medical facilities or (C) otherwise disposed of in a transaction permitted by the Indenture), (iii) all locations where the Company’s books and records concerning the Collateral are kept and (iv) whether each such Collateral location
and place of business (including the Company’s chief executive office) is owned or leased (and if leased, specifies the complete name and notice address of each lessor) or otherwise occupied (and if otherwise occupied, describes the nature of
such occupation). 
 4.5 Certain Property. None of the Collateral constitutes, or is the Proceeds of, (i) farm products, (ii) as-extracted collateral, (iii) timber to be cut or (iv) vessels, aircraft or any other personal property subject to any certificate of title or other registration statute of the United States,
any State or other jurisdiction, except for motor vehicles owned by the Company and used by employees of the Company in the Ordinary Course of Business. 

4.6 Pledged Collateral and Pledged Investment Property. 

(a) The Pledged Collateral pledged by the Company hereunder is listed on Schedule 1 and, with respect to the Pledged
Equity, constitutes all the issued and outstanding equity interests of each Issuer owned by the Company as set forth on Schedule 1. None of the Pledged Equity is a certificated security or otherwise represented or evidenced by any
certificate, and no foreign Issuer has certificated its Stock nor is the Company (or any representative, agent or any other Related Party of the Company) holding any certificate of Stock of any foreign Issuer. 

(b) All of the Pledged Equity has been duly authorized and validly issued and, in the case of shares of capital stock and membership interests,
is fully paid and nonassessable. 
 (c) Each of the Pledged Equity, Pledged Debt Instruments and Pledged Investment Property constitutes the
legal, valid and binding obligation of the obligor with respect thereto, enforceable in accordance with its terms, except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws
affecting creditors’ rights generally. 
 (d) Schedule 1A lists all Pledged Investment Property owned by the Company as of the
Closing Date. The Company is the record and beneficial owner of, and has good and valid title to, the Pledged Investment Property pledged by it hereunder. 

(e) [Reserved]. 

  
 9 

 (f) Upon the occurrence and during the continuance of an Event of Default, Agent shall be
entitled to exercise all of the rights of the Company granting the security interest in any Pledged Equity, and a transferee or assignee of such Pledged Equity shall become a holder of such Pledged Equity to the same extent as the Company and be
entitled to participate in the management of the Issuer of such Pledged Equity, and, subject to Agent’s exercise of remedies pursuant to Section 6 hereof, upon the transfer of the entire interest of the Company, the
Company shall, by operation of law, cease to be a holder of such Pledged Equity. 
 4.7 Receivables. 

(a) [Reserved]. 
 (b) [Reserved].

 4.8 [Reserved]. 
 4.9
Commercial Tort Claims. The only commercial tort claims that the Company is asserting or intends to assert in which the potential recovery exceeds $250,000 in the aggregate are those listed on Schedule 5, as may be supplemented from
time to time by delivery thereof to Agent, which sets forth such information separately for the Company. 
 4.10 Enforcement. No
material permit, notice to or filing with any Governmental Authority or any other Person or any material consent from any Person is required for the exercise by Agent of its rights (including voting rights) provided for in this Agreement or the
enforcement of remedies in respect of the Collateral pursuant to this Agreement, including the transfer of any Collateral, except (i) as may be required in connection with the disposition of any portion of the Pledged Collateral by laws
affecting the offering and sale of securities generally, (ii) any approvals that may be required to be obtained from any bailees or landlords to collect the Collateral, (iii) permits or consents which have been obtained and notices or
filings which have been made, (iv) any requirements set forth in any assignment of claims act and laws, (v) in connection with perfection methods (other than the filing of UCC financing statements) and (v) as set forth in the
Subordination and Intercreditor Agreement. 
 4.11 Accounts. Set forth on Schedule 6, as such Schedule may be updated from time
to time to reflect changes resulting from transactions permitted under the Security Documents) is a listing of all of Company’s and its Subsidiaries’ Deposit Accounts and Securities Accounts as of the Closing Date, including, with respect
to each bank or securities intermediary (a) the name and address of such Person, and (b) the account numbers of the Deposit Accounts or Securities Accounts maintained with such Person. 

4.12 Real Property. Schedule 7 sets forth all Real Property owned by any of the Company as of the Closing Date. 

4.13 Intellectual Property. As of the Closing Date: (i) Schedule 8 provides a complete and correct list of all registered
Copyrights owned by the Company and all other Copyrights owned by the Company and material to the conduct of the business of the Company; (ii) Schedule 9 provides a complete and correct list of all Intellectual Property Licenses (other
than license agreements for commercially available off-the-shelf software that is generally available to the public which have been licensed to the Company pursuant to end-user licenses) entered into by the Company that are material to the business of the Company, including any Intellectual Property Licenses that relate to Intellectual Property that is incorporated in any
Inventory, software, or other product marketed, sold, licensed, or distributed by the Company; (iii) Schedule 10 provides a complete and correct list of all Patents owned by 

  
 10 

 
the Company; and (iv) Schedule 11 provides a complete and correct list of all registered Trademarks owned by the Company and all other Trademarks owned by the Company and material to
the conduct of the business of the Company. 
 SECTION 5. COVENANTS. 

The Company covenants and agrees with Agent that, from and after the date of this Agreement until the Secured Obligations shall have been Paid
in Full: 
 5.1 [Reserved]. 

5.2 Maintenance of Perfected Security Interest; Further Documentation. 

(a) The Company shall maintain the security interests created by this Agreement as perfected security interests (to the extent such security
interests can be perfected by the filing of a UCC financing statement) by filing within the appropriate jurisdictions such financing statements (including continuation statements and necessary amendments) in accordance with the UCC. Nothing in this
Agreement or in any other Security Document shall require the Company (nor is the Agent authorized) to make any filings or take any other actions in any jurisdiction outside of the United States to record or perfect the Agent’s security
interest in any Collateral. 
 (b) [Reserved]. 

(c) [Reserved]. 
 (d) [Reserved].

 5.3 Changes in Locations, Name, etc. The Company shall not, without providing Agent with written notice within 10 Business Days of
the occurrence thereof and delivery to Agent of all additional financing statements and other documents as to the validity and perfection (by filing) of the security interests provided for herein: 

(a) [Reserved]; 
 (b) change its
jurisdiction of organization or the location of its chief executive office from that specified on Schedule 3 or in any subsequent notice delivered pursuant to this Section 5.3; or 

(c) change its name, organizational identification number (if any), identity or corporate structure, except as permitted by
Section 4.02 of the Indenture upon prior written notice thereof to the Agent. 
 5.4 [Reserved]. 

5.5 [Reserved]. 
 5.6
[Reserved]. 
 5.7 Intellectual Property. Only to the extent the First Lien Agents have also made any such request or received any
such notice, and except, in each case, where the failure to do so could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect (provided that no such Material Adverse Effect qualifier should apply to Section
5.7(b)): 
 (a) In order to facilitate filings with the United States Patent and Trademark Office and the United States Copyright Office, the
Company shall execute and record with the United States Patent and Trademark Office and the United States Copyright Office, as applicable, one or more Copyright Security Agreements, Trademark Security Agreements, or Patent Security Agreements to
further evidence Agent’s Lien on the Company’s Patents, Trademarks, or Copyrights, and the General Intangibles of the Company relating thereto or represented thereby. 

(b) At the time of delivery of (A) if Endologix is required to file reports pursuant to Section 13 or 15(d) of the Exchange Act, the 10-Q and
10K filings (or, if earlier, the time delivery thereof is required by the SEC) or (B) if Endologix is not required to file reports pursuant to Section 13 of 15(d) of the Exchange Act, concurrent with the preparation of its quarterly and annual
financial statements, the Company will notify Agent of applications filed for the registration of any Intellectual Property with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency in any
other country or any political subdivision thereof. Within five (5) Business Days of such delivery, the Company shall execute and deliver, and have recorded, any and all agreements, instruments, documents, and papers as necessary to evidence
Agent’s security interest in any Intellectual Property owned by the Company, including any Copyright, Patent or Trademark and the goodwill and general intangibles of the Company relating thereto or represented thereby. The Agent shall have no
obligation to monitor any such filings. 
 5.8 Other Matters. 

  
 11 

 (a) Without limiting the Company’s obligations under Section 5.2, the Company
authorizes Agent and its Affiliates directors, partners, officers, employees, agents, counsel and advisors to, at any time and from time to time, file or record financing statements, continuation statements, amendments thereto, and other filing or
recording documents or instruments with respect to any Collateral in such forms and in such offices as Agent or such other Person reasonably determines appropriate to perfect (by filing), or continue or maintain perfection (by filing) of, the
security interests of Agent under this Agreement, and such statements, amendments, documents, and instruments may describe the Collateral covered thereby as “all assets of the debtor” of the Company, or words of similar effect and may
contain any other information required pursuant to the UCC for the sufficiency of filing office acceptance of any financing statement, continuation statement or amendment, and the Company agrees to furnish any such information to Agent promptly upon
Agent’s reasonable request. Any such financing statement, continuation statement or amendment may be filed at any time in any jurisdiction. A copy of this Agreement shall be sufficient as a financing statement or other filing or recording
document or instrument for filing or recording in any jurisdiction. The Company also hereby ratifies its authorization for Agent and any Third Party Agent to have filed any initial financing statement or amendment thereto under the UCC (or other
similar laws) in effect in any jurisdiction if filed prior to the date hereof. To the extent permitted by law, the Company hereby (i) waives any right under the UCC or any other Applicable Law to receive notice and/or copies of any filed or
recorded financing statements, amendments thereto, continuations thereof or termination statements and (ii) releases and excuses each Secured Party from any obligation under the UCC or any other Applicable Law to provide notice or a copy of any
such filed or recorded documents. 
 (b) [Reserved]. 

(c) [Reserved]. 
 5.9
[Reserved]. 
 5.10 [Reserved]. 

5.11 Further Assurances. The Company agrees that from time to time, at its own expense, the Company will promptly (i) cause the filing of any
financing statements or continuation statements, and amendments to financing statements, or any similar document in any applicable jurisdictions and (ii) execute and deliver all intellectual property security agreements, and, in the case of each of
clause (i) and (ii) above, take all further action that may be necessary (or that Agent may reasonably request), in order to perfect and protect the security interest and Lien granted hereby, to create, perfect or protect the security interest and
Lien purported to be granted hereby or to enable Agent to exercise and enforce its rights and remedies hereunder with respect to any of the Collateral to the extent required under Section 5.7 and in each case subject to the Subordination and
Intercreditor Agreement. 
 SECTION 6. REMEDIAL PROVISIONS. 

6.1 [Reserved]. 
 6.2
[Reserved]. 
 6.3 Pledged Investment Property and Pledged Collateral. 

(a) [Reserved]. 
 (b) If an Event
of Default shall occur and be continuing and subject to the terms of the Subordination and Intercreditor Agreement: (i) Agent shall have the right to receive any and all cash dividends and distributions, payments or other Proceeds paid in
respect of the Pledged Collateral and Pledged Investment Property and make application thereof to the Secured Obligations as set forth in Section 6.5 hereof, (ii) Agent shall have the right to cause any or all of the
Pledged Collateral and Pledged Investment Property to be registered in the name of Agent or its nominee and (iii) Agent or its nominee may exercise (x) all voting, consent, corporate and other rights pertaining to such Pledged Collateral
and Pledged Investment Property at any meeting of shareholders, partners or members, as the case may be, of the relevant Issuer or Issuers or otherwise (or by written consent) and (y) any and all rights of conversion,

  
 12 

 
exchange and subscription and any other rights, privileges or options pertaining to such Pledged Collateral and Pledged Investment Property as if it were the absolute owner thereof (including the
right to exchange at its discretion any and all of the Pledged Collateral and Pledged Investment Property upon the merger, amalgamation, consolidation, reorganization, recapitalization or other fundamental change in the corporate or other structure
of any Issuer, or upon the exercise by the Company or Agent of any right, privilege or option pertaining to such Pledged Collateral and Pledged Investment Property, and in connection therewith, the right to deposit and deliver any and all of the
Pledged Collateral and Pledged Investment Property with any committee, depositary, transfer agent, registrar or other designated agency upon such terms and conditions as Agent may determine), all without Liability other than to the extent such
Liability is a result of its own willful misconduct or gross negligence as determined by a court of competent jurisdiction in a final non-appealable order or to account for property actually received by it,
but Agent shall have no duty to the Company to exercise any such right, privilege or option and shall not be responsible for any failure to do so or delay in so doing. 

(c) The Company hereby expressly and irrevocably authorizes and instructs, without any further instructions from the Company, each Issuer of
the Pledged Collateral and Pledged Investment Property pledged by the Company hereunder to during the existence of an Event of Default and subject to the Subordination and Intercreditor Agreement (i) comply with any instruction received by it
from Agent in writing that (x) states that an Event of Default has occurred and is continuing and (y) is otherwise in accordance with the terms of this Agreement, and the Company agrees that each Issuer shall be fully protected in so
complying and (ii) unless otherwise permitted under the Security Documents, pay any dividends, distributions or other payments with respect to the Pledged Collateral and Pledged Investment Property directly to Agent. 

(d) In order to permit Agent to exercise the voting and other consensual rights that it is entitled to exercise pursuant hereto and to receive
all dividends and other distributions that it is entitled to receive hereunder, during the existence of an Event of Default and subject to the Subordination and Intercreditor Agreement, the Company shall promptly execute and deliver (or cause to be
executed and delivered) to Agent all such proxies, dividend payment orders and other instruments as Agent may from time to time reasonably request. 

6.4 [Reserved]. 
 6.5
Application of Proceeds. Subject to the Subordination and Intercreditor Agreement, Agent may apply all or any part of Proceeds from the sale of, or other realization upon, all or any part of the Collateral (after deducting all reasonable and
documented external attorneys’ and other fees and out-of-pocket costs and expenses of every kind incurred in connection therewith or incidental to the care or
safekeeping of any Collateral or in any way relating to the Collateral or the rights of Agent and any other Secured Party hereunder) in payment of the Secured Obligations to the Trustee for application pursuant to Section 6.05 of the Indenture,
and may pay any other amount required by any Applicable Law. Any balance of such Proceeds remaining after the Secured Obligations shall have been Paid in Full shall be paid over to the Company or to whomsoever may be lawfully entitled to receive the
same. The parties hereto understand and agree that the exercise of remedies hereunder with respect to accounts arising under any Third Party Payor program may be subject to Applicable Law. 

6.6 Code and Other Remedies. If an Event of Default shall occur and be continuing, Agent may exercise, in addition to all other rights
and remedies granted to them in this Agreement and in any other instrument or agreement securing, evidencing or relating to the Secured Obligations, but subject to the Subordination and Intercreditor Agreement, all rights and remedies of a secured
party under the UCC or any other Applicable Law. Without limiting the generality of the foregoing, Agent, if an Event of Default shall occur and be continuing, but subject to the Subordination and Intercreditor Agreement,

  
 13 

 
without demand of performance or other demand, presentment, protest, advertisement or notice of any kind (except any notice required by law referred to below) to or upon the Company or any other
Person (all and each of which demands, defenses (other than defense of payment), advertisements and notices are hereby waived), may in such circumstances forthwith collect, receive, appropriate and realize upon the Collateral, or any part thereof,
and/or may forthwith sell, lease, assign, give options to purchase, or otherwise dispose of and deliver the Collateral or any part thereof (or contract to do any of the foregoing), in one or more parcels at public or private sale or sales, at any
exchange, broker’s board or office of Agent or elsewhere upon such terms and conditions as they may deem advisable and at such prices as it may deem best, for cash or on credit or for future delivery with assumption of any credit risk. Agent
shall have the right upon any such public sale or sales, and, to the extent permitted by law, upon any such private sale or sales, to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption in the Company,
which right or equity is hereby waived and released. The Company further agrees, at Agent’s request, if an Event of Default shall occur and be continuing, but subject to the Subordination and Intercreditor Agreement, to assemble the Collateral
and make it available to Agent at places which Agent shall reasonably select, whether at the Company’s premises or elsewhere in connection with the exercise of Agent’s remedies hereunder. Agent shall apply the net Proceeds of any action
taken by it pursuant to this Section 6.6, after deducting all reasonable documented out-of-pocket costs and expenses of every kind incurred in
connection therewith or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights of Agent hereunder, to the payment in whole or in part of the Secured Obligations, as set forth in
Section 6.5 hereof. To the extent permitted by Applicable Law, the Company waives all claims, damages and demands it may acquire against Agent arising out of the exercise by them of any rights hereunder. If any notice of a
proposed sale or other disposition of Collateral shall be required by law, such notice shall be deemed reasonable and proper if given at least 10 calendar days before such sale or other disposition. Agent shall not be obligated to make any sale of
Collateral regardless of notification of sale having been given. Agent may adjourn any public sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to
which it was so adjourned. The Company agrees that (A) the internet shall constitute a “place” for purposes of Section 9-610(b) of the Code and (B) to the extent notification of sale
shall be required by law, notification by mail of the URL where a sale will occur and the time when a sale will commence at least ten (10) days prior to the sale shall constitute a reasonable notification for purposes of Section 9-611(b) of the Code. The Company agrees that any sale of Collateral to a licensor pursuant to the terms of a license agreement between such licensor and the Company is sufficient to constitute a
commercially reasonable sale (including as to method, terms, manner, and time) within the meaning of Section 9-610 of the Code. 

6.7 Private Sale. The Company recognizes that Agent may be unable to effect a public sale of any or all the Pledged Collateral and
Pledged Investment Property, by reason of certain prohibitions contained in the Securities Act and applicable state or foreign securities laws or otherwise, or may otherwise determine that a public sale is impracticable, not desirable or not
commercially reasonable, and, accordingly, and may resort to one or more private sales thereof to a restricted group of purchasers that will be obliged to agree, among other things, to acquire such securities for their own account for investment and
not with a view to the distribution or resale thereof. The Company acknowledges and agrees that any such private sale may result in prices and other terms less favorable than if such sale were a public sale and, notwithstanding such circumstances,
agrees that any such private sale shall be deemed to have been made in a commercially reasonable manner. Agent shall be under no obligation to delay a sale of any of the Pledged Collateral or Pledged Investment Property for the period of time
necessary to permit the Issuer thereof to register such securities or other interests for public sale under the Securities Act, or under applicable state or foreign securities laws, even if such Issuer would agree to do so. 

The Company agrees to use its commercially reasonable efforts to do or cause to be done all such other acts as may be necessary to make such
sale or sales of all or any portion of the 

  
 14 

 
Pledged Collateral and Pledged Investment Property pursuant to this Section 6.7 and Section 6.10 hereof valid and binding and in compliance
with Applicable Law. The Company further agrees that a breach of any of the covenants contained herein will cause irreparable injury to Agent and the other Secured Parties, that Agent and the other Secured Parties have no adequate remedy at law in
respect of such breach and, as a consequence, that each and every covenant contained herein shall be specifically enforceable against the Company (except as such enforceability may be limited by applicable insolvency, bankruptcy, reorganization,
moratorium or other similar laws affecting creditors’ rights generally), and the Company hereby waives and agrees not to assert any defenses against an action for specific performance of such covenants. Until all of the Secured Obligations are
Paid in Full, the Company postpones until such date any and all rights of contribution or subrogation upon the sale or disposition of all or any portion of the Pledged Collateral and Pledged Investment Property by Agent. 

6.8 Deficiency. The Company shall remain liable for any deficiency if the Proceeds of any sale or other disposition of any Collateral
are insufficient to Pay in Full the Secured Obligations and the fees and disbursements of any attorneys employed by Agent or any other Secured Party to collect such deficiency. 

6.9 Licenses. Solely for the purpose of enabling Agent (for the benefit of the Secured Parties) to exercise rights and remedies
following and during the continuation of an Event of Default (including in order to take possession of, collect, receive, assemble, process, appropriate, remove, realize upon, sell, assign, convey, transfer or grant options to purchase any
Collateral), the Company hereby grants to Agent, for the benefit of the Secured Parties, (i) an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to the Company) including in such license the right
to use, practice, license or sublicense any Intellectual Property now owned or hereafter acquired by the Company, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be
recorded or stored and to all computer software and programs used for the compilation or printout thereof, and (ii) an irrevocable license (without payment of rent or other compensation to the Company) to use, operate and occupy all Real Estate
owned, operated, leased, subleased or otherwise occupied by the Company; provided, in each case, that no such licenses shall be granted with respect to any Excluded Property. 

6.10 Disposition of Collateral. Without limiting the generality of the foregoing, to the fullest extent not prohibited by Applicable
Law, Agent may, without demand of performance or other demand, presentment, protest, advertisement or notice of any kind (except any notice required by law referred to below) to or upon the Company or any other Person (all and each of which demands,
defenses, advertisements and notices are hereby waived), upon the occurrence and during the continuance of any Event of Default (personally or through its agents or attorneys), but subject to the Subordination and Intercreditor Agreement,
(i) enter upon the premises where any Collateral is located, without any obligation to pay rent, through self-help, without judicial process, without first obtaining a final judgment or giving the Company or any other Person notice or
opportunity for a hearing on Agent’s claim or action, (ii) collect, receive, appropriate and realize upon any Collateral and (iii) sell, assign, convey, transfer, grant option or options to purchase and deliver any Collateral (and
enter into contractual obligations to do any of the foregoing), in one or more parcels at public or private sale or sales, at any exchange, broker’s board or office of any Secured Party or elsewhere upon such terms and conditions as it may deem
advisable and at such prices as it may deem best, for cash or on credit or for future delivery without assumption of any credit risk. Agent shall have the right, upon any such public sale or sales and, to the extent permitted by the UCC and other
Applicable Law, upon any such private sale, to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption of the Company, which right or equity is hereby waived and released. 

  
 15 

 6.11 Management of the Collateral. The Company further agrees, that, upon the
occurrence and during the continuance of any Event of Default and to the fullest extent not prohibited by Applicable Law and, in each case, subject to the terms of the Subordination and Intercreditor Agreement (if applicable), (i) at Agent’s
written request, it shall assemble the Collateral and make it available to Agent at places that Agent shall reasonably select, whether at the Company’s premises or elsewhere (including without limitation, causing any Collateral located outside
of the United States to be delivered to a location inside the United States), (ii) without limiting the foregoing, Agent also has the right to require that the Company store and keep any Collateral pending further action by Agent and, while any such
Collateral is so stored or kept, provide such guards and maintenance services as shall be necessary to protect the same and to preserve and maintain such Collateral in good condition, (iii) until Agent is able to sell, assign, convey or
transfer any Collateral, Agent shall have the right to hold or use such Collateral to the extent that it deems appropriate for the purpose of preserving the Collateral or its value or for any other purpose deemed appropriate by Agent, and
(iv) Agent may, if it so elects, seek the appointment of a receiver or keeper to take possession of any Collateral and to enforce any of Agent’s remedies (for the benefit of the Secured Parties), with respect to such appointment without
prior notice or hearing as to such appointment. Agent shall not have any obligation to the Company to maintain or preserve the rights of the Company as against third parties with respect to any Collateral while such Collateral is in the possession
of Agent. 
 6.12 Direct Obligation. Neither Agent nor any other Secured Party shall be required to make any demand upon, or pursue or
exhaust any right or remedy against, the Company or any other Person with respect to the payment of the Secured Obligations or to pursue or exhaust any right or remedy with respect to any Collateral therefor or any direct or indirect guaranty
thereof All of the rights and remedies of Agent and any other Secured Party under any Security Document shall be cumulative, may be exercised individually or concurrently and not exclusive of any other rights or remedies provided by any Applicable
Law. To the extent it may lawfully do so, the Company absolutely and irrevocably waives and relinquishes the benefit and advantage of, and covenants not to assert against Agent or any other Secured Party, any valuation, stay, appraisement,
extension, redemption or similar laws and any and all rights or defenses it may have as a surety, now or hereafter existing, arising out of the exercise by them of any rights hereunder. If any notice of a proposed sale or other disposition of any
Collateral shall be required by law, such notice shall be deemed reasonable and proper if given at least ten (10) calendar days before such sale or other disposition. 

6.13 Commercially Reasonable. To the extent that any Applicable Law impose duties on Agent to exercise remedies in a commercially
reasonable manner, the Company acknowledges and agrees that it is not commercially unreasonable for Agent to do any of the following: 
 (a)
fail to incur significant costs, expenses or other Liabilities reasonably deemed as such by Agent to prepare any Collateral for disposition or otherwise to complete raw material or work in process into finished goods or other finished products for
disposition; 
 (b) fail to obtain permits, or other consents, for access to any Collateral to sell or for the collection or sale of any
Collateral, or, if not required by other Applicable Law, fail to obtain Permits or other consents for the collection or disposition of any Collateral; 

(c) fail to exercise remedies against account debtors or other Persons obligated on any Collateral or to remove Liens on any Collateral or to
remove any adverse claims against any Collateral; 

  
 16 

 (d) advertise dispositions of any Collateral through publications or media of general
circulation, whether or not such Collateral is of a specialized nature, or to contact other Persons, whether or not in the same business as the Company, for expressions of interest in acquiring any such Collateral; 

(e) exercise collection remedies against account debtors and other Persons obligated on any Collateral, directly or through the use of
collection agencies or other collection specialists, hire one or more professional auctioneers to assist in the disposition of any Collateral, whether or not such Collateral is of a specialized nature, or, to the extent deemed appropriate by Agent,
obtain the services of other brokers, investment bankers, consultants and other professionals to assist Agent in the collection or disposition of any Collateral, or utilize Internet sites that provide for the auction of assets of the types included
in the Collateral or that have the reasonable capacity of doing so, or that match buyers and sellers of assets to dispose of any Collateral; 

(f) dispose of assets in wholesale rather than retail markets; 

(g) disclaim disposition warranties, such as title, possession or quiet enjoyment; or 

(h) purchase insurance or credit enhancements to insure Agent against risks of loss, collection or disposition of any Collateral or to provide
to Agent a guaranteed return from the collection or disposition of any Collateral. 
 The Company acknowledges that the purpose of this
Section 6.13 is to provide a non-exhaustive list of actions or omissions that are commercially reasonable when exercising remedies against any Collateral and that other actions or
omissions by any Secured Party shall not be deemed commercially unreasonable solely on account of not being indicated in this Section 6.13. Without limitation upon the foregoing, nothing contained in this
Section 6.13 shall be construed to grant any rights to the Company or to impose any duties on Agent or any other Secured Party that would not have been granted or imposed by this Agreement or by Applicable Law in the
absence of this Section 6.13. 
 SECTION 7. AGENT. 

7.1 Agent’s Appointment as Attorney-in-Fact. 

(a) The Company hereby irrevocably constitutes and appoints Agent and any Affiliates, directors, partners, officers, employees, agents, counsel
and advisors thereof, with full power of substitution, as its true and lawful attorney-in-fact with full power and authority in the place and stead of the Company and in
the name of the Company or in its own name, for the purpose of carrying out the terms of the Security Documents, to, upon the occurrence and during the continuance of an Event of Default, but subject to the Subordination and Intercreditor Agreement,
take any appropriate action and to execute any document or instrument that may be necessary or desirable to accomplish the purposes of the Security Documents, and, without limiting the generality of the foregoing, the Company hereby gives Agent and
its Affiliates, directors, partners, officers, employees, agents, counsel and advisors the power and right, on behalf of the Company, without notice to or assent by the Company, to do any of the following when an Event of Default has occurred and is
continuing (subject to the Subordination and Intercreditor Agreement and, as applicable, to compliance by Agent with Applicable Law with respect to Accounts arising under any Third Party Payor programs): 

(i) in the name of the Company, in its own name or otherwise, take possession of and indorse and collect any check, draft,
note, acceptance or other instrument for the payment of moneys due under any account or general intangible that is Collateral or with respect to any other 

  
 17 

 
Collateral and file any claim or take any other action or proceeding in any court of law or equity or otherwise deemed appropriate by Agent for the purpose of collecting any such moneys due under
any account or general intangible that is Collateral or with respect to any other Collateral whenever payable; 
 (ii) in the
case of any Intellectual Property owned by and, in the case of Copyrights, exclusively licensed to the Company (to the extent not constituting Excluded Property and to the extent permitted under the applicable Intellectual Property), execute,
deliver and have recorded any document that Agent may request in accordance with this Agreement to evidence, effect, publicize or record Agent’s security interest in such Intellectual Property and the goodwill and general intangibles of the
Company relating thereto or represented thereby; 
 (iii) pay or discharge taxes and Liens levied or placed on or threatened
against any Collateral, effect any repair or pay any insurance called for by the terms of the Indenture (including all or any part of the premiums therefor and the costs thereof); 

(iv) execute, in connection with any sale provided for in Section 6.7 or
Section 6.10 hereof, any document to effect or otherwise necessary or appropriate in relation to evidence the sale of any Collateral; or 

(v) (A) direct any party liable for any payment under any Collateral to make payment of any moneys due or to become due
thereunder directly to Agent or as Agent shall direct, (B) ask or demand for, and collect and receive payment of and receipt for, any moneys, claims and other amounts due or to become due at any time in respect of or arising out of any
Collateral, (C) sign and indorse any invoice, freight or express bill, bill of lading, storage or warehouse receipt, draft against debtors, assignment, verification, notice and other document in connection with any Collateral, (D) commence
and prosecute any suit, action or proceeding at law or in equity in any court of competent jurisdiction to collect any Collateral and to enforce any other right in respect of any Collateral, (E) defend any actions, suits, proceedings, audits,
claims, demands, orders or disputes brought against the Company with respect to any Collateral, (F) settle, compromise or adjust any such actions, suits, proceedings, audits, claims, demands, orders or disputes that are related to Collateral
and, in connection therewith, give such discharges or releases as Agent may deem appropriate, (G) assign any Intellectual Property owned by the Company or any Intellectual Property Licenses of the Company where the Company is the licensor
thereunder (to the extent not constituting Excluded Property and to the extent permitted under the applicable Intellectual Property or Intellectual Property License, as applicable) throughout the world on such terms and conditions and in such manner
as Agent shall in its sole discretion determine (except, with respect to Trademarks, subject to reasonable quality control in favor of the Company), including the execution and filing of any document necessary to effectuate or record such
assignment, or (H) generally, sell, assign, convey, transfer or grant a Lien on, make any Contractual Obligation with respect to and otherwise deal with, any Collateral as fully and completely as though Agent were the absolute owner thereof for
all purposes and do, at Agent’s option, at any time or from time to time, all acts and things that Agent deems necessary to protect, preserve or realize upon any Collateral and the Secured Parties’ security interests therein and to effect
the intent of the Security Documents, all as fully and effectively as the Company might do; 
 (vi) if the Company fails to
perform or comply with any Contractual Obligation contained herein, then during the existence of an Event of Default, Agent, at its option, but without any obligation so to do, may perform or comply, or otherwise cause performance or compliance,
with such Contractual Obligation; 

  
 18 

 (vii) receive and open all mail addressed to the Company and to notify
postal authorities to change the address for the delivery of mail to the Company to that of Agent; or 
 (viii) use any
Intellectual Property or Intellectual Property Licenses of the Company, including but not limited to any labels, Patents, Trademarks, trade names, URLs, domain names, industrial designs, Copyrights, or advertising matter, in preparing for sale,
advertising for sale, or selling Inventory or other Collateral and to collect any amounts due under Accounts, contracts or negotiable Collateral of the Company. 

(b) The expenses of Agent incurred in connection with actions undertaken as provided in this Section 7.1, from the
date of payment by Agent to the date reimbursed by the Company, shall be payable by the Company to Agent on written demand by Agent to the Company. 

(c) The Company hereby ratifies all that said attorneys shall lawfully do or cause to be done by virtue of, and in accordance with, this
Section 7.1. All powers, authorizations and agencies contained in this Agreement are coupled with an interest and are irrevocable until this Agreement is terminated and the security interests created hereby are released.

 7.2 Authority of Agent. The Company acknowledges that the rights and responsibilities of Agent under this Agreement with respect to
any action taken by Agent or the exercise or non-exercise by Agent of any option, voting right, request, judgment or other right or remedy provided for herein or resulting or arising out of this Agreement
shall, as between Agent and the other Secured Parties, be governed by the Indenture and by such other agreements with respect thereto as may exist from time to time among them, but, as between Agent and the Company, Agent shall be conclusively
presumed to be acting as agent for the Secured Parties with full and valid authority so to act or refrain from acting, and the Company shall not be under any obligation or entitlement to make any inquiry respecting such authority. 

7.3 Duty; Obligations and Liabilities. 

(a) Agent’s sole duty with respect to the custody, safekeeping and physical preservation of the Collateral in its possession shall be to
deal with it in the same manner as Agent deals with similar property for its own account. The powers conferred on Agent hereunder are solely to protect Agent’s interest in the Collateral and shall not impose any duty upon Agent to exercise any
such powers. Agent shall be accountable only for amounts that it receives as a result of the exercise of such powers, and neither it nor any of its Affiliates, directors, partners, officers, employees, agents, counsel or advisors shall be
responsible to the Company or any other Person for any act or failure to act hereunder, except for their own gross negligence or willful misconduct, in each case, as determined by a court of competent jurisdiction in a final non-appealable order. In addition, Agent shall not be liable or responsible for any loss or damage to any Collateral, or for any diminution in the value thereof, by reason of the act or omission of any warehousemen,
carrier, forwarding agency, consignee or other bailee if such Person has been selected by Agent in good faith. 
 (b) No Secured Party and no
Affiliates, directors, partners, officers, employees, agents, counsel or advisors thereof shall be liable for failure to demand, collect or realize upon any Collateral or for any delay in doing so or shall be under any obligation to sell or
otherwise dispose of any Collateral upon the request of the Company or any other Person or to take any other action whatsoever with regard to any Collateral. The powers conferred on Agent hereunder shall not impose any duty upon any other Secured
Party to exercise any such powers. The other Secured Parties shall be accountable only for amounts that they actually receive as a result of the exercise of such powers, and neither they nor any of their respective officers, directors, employees or
agents shall be responsible to the Company for any act 

  
 19 

 
or failure to act hereunder, except for their own gross negligence or willful misconduct as determined by a court of competent jurisdiction in a final
non-appealable order. 
 (c) The Agent shall not have any duties or obligations except those
expressly set forth herein. Without limiting the generality of the foregoing, the Agent (i) shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred and is continuing, (ii) shall
not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby that the Agent is required to exercise as directed in writing by Holders of a majority in
aggregate outstanding amount of the Notes outstanding (or by the Trustee acting upon such direction); provided that the Collateral Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the
Collateral Agent to liability, for which it is not indemnified to its satisfaction, or that is contrary to this Agreement or applicable law, (iii) shall not be liable for any action taken or not taken by it (1) with the consent or at the
request Holders or the Trustee or (2) in the absence of its own gross negligence, willful misconduct or (3) in reliance on a certificate of an authorized officer of the Company stating that such action is permitted by the terms of this
Agreement and the Indenture. 
 (d) The Agent shall not be responsible for or have any duty to ascertain or inquire into (1) any
statement, warranty or representation made in or in connection with this Agreement, (2) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (3) the performance
or observance by any other Person of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default or Event of Default, (4) the validity, enforceability, effectiveness or genuineness
of this Agreement, any other Security Document, the Subordination and Intercreditor Agreement or any other agreement, instrument or document, or the creation, perfection or priority of any Lien purported to be created by the security interest,
(5) the value or the sufficiency of any Collateral or (6) the satisfaction of any condition set forth in any agreement, other than to confirm receipt of items expressly required to be delivered to the Agent. 

(e) The Agent may resign at any time by giving written notice thereof to the Company and the Trustee; provided that no such resignation shall
take effect until a successor Agent has been appointed and has agreed to act as such under this Agreement and the Indenture. Upon notice of any such resignation, the Company shall promptly (and no later than within 30 days) appoint a successor to
the Agent. Upon the acceptance of any appointment as Agent hereunder by a successor Agent, such successor Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring Agent, and the retiring
Agent shall be discharged from its duties and obligations. After any retiring Agent’s resignation as Agent, the provisions of this Agreement shall inure to its benefit as to any actions taken or omitted to be taken by it while it was Agent. If
the Company fails to appoint a successor Agent within 30 days, the Agent may (at the Company’s expense) petition a court of competent jurisdiction to do so. 

(f) No provision of the Indenture or any Security Document will require the Agent to expend or risk its own funds or incur any financial
liability in the performance of any of its duties hereunder or under any other Security Document or the Indenture or in the exercise of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or
adequate indemnity against such risk or liability is not reasonably assured to it. The Agent will be under no obligation to exercise any of its rights and powers hereunder or under the Indenture or any other Security Document at the request or
direction of the Trustee or the Holders of a majority in aggregate principal amount of Notes outstanding, unless it has been offered security or indemnity reasonably satisfactory to it against any loss, liability or expense. 

  
 20 

 (g) The Collateral Agent shall have no obligation whatsoever to assure that the Collateral
exists or is owned by the Company or is cared for, protected, or insured or has been encumbered, or that the Collateral Agent’s Liens have been properly or sufficiently or lawfully created, perfected, protected, maintained or enforced or are
entitled to any particular priority, or to determine whether the Company’s property constituting collateral intended to be subject to the Lien and security interest of the Security Documents has been properly and completely listed or delivered,
as the case may be, or the genuineness, validity, marketability or sufficiency thereof or title thereto, or to exercise at all or in any particular manner or under any duty of care, disclosure, or fidelity, or to continue exercising, any of the
rights, authorities, and powers granted or available to the Collateral Agent pursuant to the Indenture or any Security Document other than pursuant to the instructions of the Holders of a majority in aggregate outstanding amount of the Notes
outstanding in accordance with the Indenture or as otherwise provided in the Security Documents, it being understood and agreed that in respect of the Collateral, or any act, omission, or event related thereto, the Collateral Agent shall have no
other duty or liability whatsoever to the Trustee or any Holder as to any of the foregoing. 
 (h) Without limiting the foregoing, with
respect to any Collateral located outside of the United States (“Foreign Collateral”), the Agent shall have no obligation to directly enforce, or exercise rights and remedies in respect of, or otherwise exercise any judicial action
or appear before any court in any jurisdiction outside of the United States. To the extent the Holders of a majority in aggregate outstanding amount of Notes outstanding determine that it is necessary or advisable in connection with any enforcement
or exercise of rights with respect to Foreign Collateral to exercise any judicial action or appear before any such court, the Holders of a majority in aggregate outstanding amount of Notes outstanding shall be entitled to direct the Agent to appoint
a local agent for such purpose (subject to the receipt of such protections, security and indemnities as the Agent shall determine in its sole discretion to protect the Agent from liability). 

(i) The Agent shall enjoy all the rights, benefits, protections, immunities and indemnities granted to it under the Indenture. 

SECTION 8. MISCELLANEOUS. 
 8.1
Amendments in Writing. The provisions of this Agreement may be waived, modified, supplemented or amended only by an instrument in writing signed by the Company and Agent in accordance with the procedures set forth in Article X of the
Indenture; provided, however, that annexes and schedules, as applicable, to this Agreement may be supplemented or modified (but no existing provisions may be modified and no Collateral may be released, except with respect to the
removal of items on the schedules in connection with a sale or other disposition of Collateral, a merger or Acquisition, in each case, that is permitted under the Indenture) as set forth in Section 5 and
Section 8.15 hereof. Notwithstanding anything to the contrary in the first sentence of this Section 8.1, any time period for performance under this Agreement may be extended, at any time, by Agent
in its sole discretion. The Agent shall have no obligation to enter into any amendment, supplement or waiver that affects its rights, obligations, immunities or indemnities. All fees, costs and expenses (including reasonable attorneys’ fees,
costs and expenses) incurred in connection with any amendment, supplement or waiver shall be payable by the Company. 
 8.2 Notices.
All notices, requests and demands to or upon Agent or the Company hereunder shall be addressed to such party and effected in the manner provided for in [Article XI] of the Indenture. 

8.3 Indemnification by Company. The Company agrees to indemnify, pay, and hold Agent, the other Secured Parties and the Secured
Parties’ Affiliates, officers, directors, employees, agents, 

  
 21 

 
and attorneys (the “Indemnitees”) harmless against losses and Liabilities to the extent set forth in Section 7.06 of the Indenture, the terms of which
are incorporated herein by reference as though set forth fully herein. The provisions in this Section 8.3 shall survive Payment in Full of all Secured Obligations, any foreclosure under, or any modification, release or
discharge of, any or all of the Collateral, and termination of this Agreement. 
 8.4 Enforcement Expenses. 

(a) The terms of Section 7.06 of the Indenture with respect to costs and expenses are incorporated herein by
reference, mutatis mutandis, and the parties hereto agree to such terms. 
 (b) The agreements in this
Section 8.4 shall survive Payment in Full of all Secured Obligations, any foreclosure under, or any modification, release or discharge of, any or all of the Collateral, and termination of this Agreement. 

8.5 Nature of Remedies. All Secured Obligations of the Company and rights of Agent and the other Secured Parties expressed herein or in
any other Security Document shall be in addition to and not in limitation of those provided by Applicable Law but in any event subject to the Subordination and Intercreditor Agreement. No failure to exercise and no delay in exercising, on the part
of Agent or the other Secured Parties, any right, remedy, power or privilege hereunder, shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further
exercise thereof or the exercise of any other right, remedy, power or privilege. 
 8.6 Counterparts; Effectiveness. This Agreement
may be executed in several counterparts, and by each Party on separate counterparts, each of which and any photocopies, facsimile copies and other electronic methods of transmission thereof shall be deemed an original, but all of which together
shall constitute one and the same agreement. 
 8.7 Severability. If any provision of this Agreement or any of the other Security
Documents shall be invalid, illegal or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions hereof or thereof shall not in any way be affected or impaired thereby. The parties hereto shall
endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provision. 

8.8 Entire Agreement. Subject to the Subordination and Intercreditor Agreement, this Agreement contains the entire understanding of the
parties hereto with respect to the matters covered hereby and supersedes any and all other written and oral communications, negotiations, commitments and writings with respect thereto. All Exhibits, Schedules and Annexes referred to herein are
incorporated in this Agreement by reference and constitute a part of this Agreement. If any provision contained in this Agreement conflicts with any provision of the Indenture, then with regard to such conflicting provisions, the Indenture shall
govern and control. 
 8.9 Successors; Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto
and their respective successors and permitted assigns, except, notwithstanding anything to the contrary in this Agreement or any other Security Document, that the Company may not assign their rights or obligations hereunder and any such purported,
prohibited or attempted assignment shall be void ab initio. 

  
 22 

 8.10 Applicable Law. THE VALIDITY OF THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS
(UNLESS EXPRESSLY PROVIDED TO THE CONTRARY IN ANOTHER LOAN DOCUMENT IN RESPECT OF SUCH OTHER LOAN DOCUMENT), THE CONSTRUCTION, INTERPRETATION, AND ENFORCEMENT HEREOF AND THEREOF, THE RIGHTS OF THE PARTIES HERETO AND THERETO WITH RESPECT TO ALL
MATTERS ARISING HEREUNDER OR THEREUNDER OR RELATED HERETO OR THERETO, AND ANY CLAIMS, CONTROVERSIES OR DISPUTES ARISING HEREUNDER OR THEREUNDER OR RELATED HERETO OR THERETO SHALL BE DETERMINED UNDER, GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK. 
 8.11 Consent to Jurisdiction; Venue. 

(a) THE COMPANY HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE COMMERCIAL DIVISION NEW YORK STATE SUPREME
COURT AND THE FEDERAL COURTS, IN EACH CASE, SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN (AND, IN EACH CASE, THE APPLICABLE STATE AND FEDERAL APPEALS COURTS SITTING IN THE CITY OF NEW YORK OR, IF NOT AVAILABLE OR APPLICABLE, THE STATE OF
NEW YORK), IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO ANY LOAN DOCUMENTS, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE
AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT AGENT MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING
RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST ANY LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. 
 (b) THE
PARTIES AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION WITH THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS SHALL BE TRIED AND LITIGATED ONLY IN THE STATE AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, FEDERAL COURTS LOCATED IN THE COUNTY
OF NEW YORK, STATE OF NEW YORK; PROVIDED, THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE BROUGHT, AT AGENT’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE AGENT ELECTS TO BRING SUCH ACTION OR WHERE
SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND. THE COMPANY AND EACH MEMBER OF THE LENDER GROUP WAIVE, TO THE EXTENT PERMITTED UNDER APPLICABLE LAW, ANY RIGHT EACH MAY HAVE TO ASSERT THE DOCTRINE OF FORUM NON CONVENIENS OR TO OBJECT TO VENUE TO THE
EXTENT ANY PROCEEDING IS BROUGHT IN ACCORDANCE WITH THIS SECTION 8.11. 
 8.12 Waiver of Jury Trial. TO THE MAXIMUM EXTENT
PERMITTED BY APPLICABLE LAW, THE COMPANY AND THE AGENT HEREBY WAIVE THEIR RESPECTIVE RIGHTS, IF ANY, TO A JURY TRIAL OF ANY CLAIM, CONTROVERSY, DISPUTE OR CAUSE OF ACTION DIRECTLY OR INDIRECTLY BASED UPON OR ARISING OUT OF ANY OF THE LOAN DOCUMENTS
OR ANY OF THE TRANSACTIONS CONTEMPLATED THEREIN, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW OR STATUTORY CLAIMS (EACH A “CLAIM”). THE COMPANY AND THE AGENT REPRESENT THAT EACH HAS
REVIEWED THIS WAIVER AND EACH KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING 

  
 23 

 
CONSULTATION WITH LEGAL COUNSEL. IN THE EVENT OF LITIGATION, A COPY OF THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 

8.13 [Reserved]. 
 8.14
Acknowledgements. The Company hereby acknowledges that: 
 (a) it has been advised by counsel in the negotiation, execution and
delivery of this Agreement, the other Security Documents to which it is a party and the Subordination and Intercreditor Agreement; 
 (b)
Neither Agent nor any other Secured Party have any fiduciary relationship with or duty to the Company arising out of or in connection with this Agreement or any of the other Security Documents, and the relationship between the Company, on the one
hand, and Agent and the other Secured Parties, on the other hand, in connection herewith or therewith is solely that of debtor and creditor; and 

(c) no joint venture is created hereby or by the other Security Documents or otherwise exists by virtue of the transactions contemplated hereby
among the Company and the Secured Parties. 
 8.15 [Reserved]. 

8.16 Releases. 
 (a) At
such time as the Secured Obligations have been Paid in Full, the Collateral shall be automatically released from the Liens created hereby and this Agreement shall automatically terminate (other than those provisions expressly surviving the Payment
in Full of the Secured Obligations), all without delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall automatically revert to the Company. At the request and sole expense of the Company following
any such Payment in Full of the Secured Obligations, Agent shall promptly deliver to the Company any Collateral held by Agent hereunder, and execute and deliver to the Company such documents as the Company shall reasonably request in writing to
evidence the termination and release of the Liens in the Collateral upon delivery of an Officers’ Certificate and Opinion of Counsel pursuant to Section 16.02 of the Indenture. 

(b) If any of the Collateral shall be sold, transferred or otherwise disposed of by the Company in a transaction permitted by the Indenture or
as otherwise provided in the Subordination and Intercreditor Agreement, then such Collateral shall be automatically released from the Liens created hereby and this Agreement shall automatically terminate with respect to such Collateral, all without
delivery of any instrument or performance of any act by any party, and all rights to the Collateral shall automatically revert to the Company. At the request and sole expense of the Company following any such release, Agent shall promptly deliver to
the Company any such Collateral held by Agent hereunder, and execute and deliver to the Company such documents as the Company shall reasonably request in writing to evidence the termination and release of the Liens in such Collateral;
provided that the Company shall have delivered to Agent, with reasonable notice prior to the date of the proposed release, a written request for release identifying the Company, together with an Officers’ Certificate and Opinion of
Counsel pursuant to Section 16.02 of the Indenture. 
 (c) [Reserved]. 

  
 24 

 8.17 [Reserved]. 

8.18 Reinstatement. The Company agrees that, if any payment made by the Company or other Person and applied to the Secured Obligations
is at any time annulled, avoided, set aside, rescinded, invalidated, declared to be fraudulent or preferential or otherwise required to be refunded or repaid, or the Proceeds of any Collateral are required to be returned by any Secured Party to the
Company, its estate, trustee, receiver or any other party, including the Company, under any applicable bankruptcy law, state or federal law, common law or equitable cause, then, to the extent such payment or repayment is annulled, avoided, set
aside, rescinded, invalidated, refunded, repaid or returned, any Lien or other Collateral securing such liability with respect to the Secured Obligations shall be and remain in full force and effect, as fully as if such payment had never been made.
If, prior to any of the foregoing, any Lien or other Collateral securing the Company’s Secured Obligations shall have been released or terminated by virtue of the foregoing, such Lien shall be reinstated in full force and effect and such prior
release, termination, cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect the obligations of any the Company in respect of any Lien or other Collateral securing such obligation or the amount of such payment.
This Section 8.18 shall survive the termination of this Agreement pursuant to Section 8.16 or otherwise. The provisions in this Section 8.18 shall survive Payment in Full
of all Secured Obligations, any foreclosure under, or any modification, release or discharge of, any or all of the Collateral, and termination of this Agreement. 

8.19 [Reserved]. 
 8.20
No Waiver by Course of Conduct. No Secured Party shall by any act, delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any Default or Event of Default. No failure to
exercise, nor any delay in exercising, on the part of any Secured Party, any right, power or privilege hereunder or under any other Security Document shall operate as a waiver thereof No single or partial exercise of any right, power or privilege
hereunder or under any other Security Document shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege. A waiver by any Secured Party of any right or remedy hereunder or any other Security Document
on any one occasion shall not be construed as a bar to any right or remedy that such Secured Party would otherwise have on any future occasion. 

8.21 Subordination and Intercreditor Agreement. Notwithstanding anything herein to the contrary, the Liens and security interest granted
to the Collateral Agent pursuant to or in connection with this Agreement or any other Security Document and the exercise of any right or remedy by the Collateral Agent or any other Secured Party hereunder or thereunder, (i) are expressly subject and
subordinate to the liens and security interests granted in favor of the First Lien Agents and (ii) are subject in all respects to the terms and provisions set forth in the Subordination and Intercreditor Agreement. In the event of any conflict
between any provision in this Agreement, the Indenture or any other Security Document (other than the Subordination and Intercreditor Agreement) and a provision in the Subordination and Intercreditor Agreement, such provision of the Subordination
and Intercreditor Agreement shall control. Any Collateral held by (or in the possession or control of) the Facility Agent (or its agents or bailees) or the ABL Agent (or its agents or bailees) shall be deemed to be held by the Agent in satisfaction
of the requirements of this Agreement. In addition, any Collateral deemed held by (or in the possession or control of) the Facility Agent (or its agents or bailees) or the ABL Agent (or its agents or bailees) as agent and bailee in favor of Agent
(for the benefit of the Secured Parties) shall be subject to the terms of the Subordination and Intercreditor Agreement. 
 8.22 Relation
to Other Security Documents. The provisions of this Agreement shall be read and construed with the other Security Documents referred to below in the manner so indicated. 

(a) The provisions of the Copyright Security Agreements, Trademark Security Agreements, and Patent Security Agreements are supplemental to the
provisions of this Agreement and subject to the terms of the Subordination and Intercreditor Agreement, and nothing contained in the Copyright Security Agreements, Trademark Security Agreements, or the Patent Security Agreements

  
 25 

 
shall limit any of the rights or remedies of Agent hereunder. In the event of any conflict between any provision in this Agreement and a provision in a Copyright Security Agreement, Trademark
Security Agreement or Patent Security Agreement, such provision of this Agreement shall control. 
 [SIGNATURE PAGES FOLLOW] 

  
 26 

 IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly executed
and delivered as of the date first above written. 
  

							
	COMPANY:	 	            	  	ENDOLOGIX, INC.,
		 		  	a Delaware corporation,
				
		 		  	By:	  	 /s/ Vaseem Mahboob

		 		  	Name:   Vaseem Mahboob
		 		  	Title:     Chief Financial Officer

  
 [Signature Page to Junior
Lien Security Agreement] 

							
	AGENT:	 	        	  	WILMINGTON TRUST, NATIONAL ASSOCIATION, as Collateral Agent
				
		 		  	By:	  	
                 

		 		  	Name:
		 		  	Title:

  
 [Signature Page to Junior
Lien Security Agreement] 

 SCHEDULE 1 

PLEDGED EQUITY AND PLEDGED DEBT INSTRUMENTS 

Pledged Equity: 
  

																									
	 Company
 (owner of

Record of
 such Pledged

Equity)
	  	Issuer	 	  	Par Value	 	  	No. of
Shares,
Units or
Interests
Owned	 	  	Total
Shares,
Units or
Interests
Authorized
and
Outstanding	 	  	Percentage
of Shares,
Units or
Interests
Owned	 	  	Certificate
(Indicate
No.)	 
	 N.A.
	  				  				  				  				  				  			

 Pledged Debt Instruments: 
  

																					
	 Company (owner
 of Record of
such
 Pledged Debt

Instrument)
	  	Issuer	 	  	Description of Debt	 	  	Final
Maturity	 	  	Principal
Amount	 	  	Certificate
(Indicate
No.)	 
	 N.A.
	  				  				  				  				  			

 SCHEDULE 1A 

PLEDGED INVESTMENT PROPERTY 
 None.

 SCHEDULE 2 

FILINGS AND PERFECTION 
 To be
attached. 

 SCHEDULE 3 

COMPANY INFORMATION 
  

									
	 COMPANY

(exact legal name)
	  	STATE/COUNTRY
OF
ORGANIZATION	  	FEDERAL
EMPLOYER
IDENTIFICATION
NUMBER	  	CHIEF EXECUTIVE
OFFICE	  	ORGANIZATIONAL
IDENTIFICATION
NUMBER
	 Endologix, Inc.
	  	Delaware	  	68-0328265	  	2 Musick, Irvine, County
 of Orange, CA 92618 U.S.A.
	  	2338745

 SCHEDULE 4 

PLACES OF BUSINESS / LOCATION OF COLLATERAL 
  

									
	 Company
	  	 Location
	  	 Specify

Whether
 Location

Has
 (i) Inventory

and/or
 Equipment,

(ii) Books
 and

Records, or
 (iii)
Both
	  	 Interest
	  	 Lessor/Property

Owner/Lessee

	Endologix, Inc.	  	 2 Musick, Irvine,
 County of Orange,

CA 92618 U.S.A.
	  	Both	  	Lease	  	 The Northwestern
 Mutual Life Insurance

Company, att: William
 A. Budge, 19

Hammond, Suite 501,
 Irvine, California 92618

					
	Endologix, Inc.	  	 33 & 35
 Hammond, Irvine,

County of Orange,
 CA 92618 U.S.A
	  	 Inventory and/or

Equipment
	  	Lease	  	 The Northwestern
 Mutual Life

Insurance Company,
 att: William A.

Budge, 19
 Hammond, Suite

501, Irvine,
 California 92618

					
	Endologix, Inc.	  	 378 Commercial
 Street, Malden, MA

02148
  

165 Chubb Avenue,
 Lyndhurst, NJ 07071

 
 1130 Commerce

Blvd, Swedesboro, NJ
 08085

 
 2250 Outerloop

Drive, Louisville,
 KY 40219
	  	 Inventory

and/or
 Equipment
	  	 Third

Party
 Warehouse
	  	UPS
					
	Endologix, Inc.	  	 6 Raflles Quay

#16-01 Singapore

048580
	  	 Inventory

and/or
 Equipment (no other

Collateral is located
 at this
location)
	  	Occupied	  	 Endologix Singapore
 Private
Limited

					
	Endologix, Inc.	  	 A-311, M-Sate,

114 Beopwon-ro,
	  	 Inventory

and/or
	  	Occupied	  	N.A.

									
	 Company
	  	 Location
	  	 Specify

Whether
 Location

Has
 (i) Inventory

and/or
 Equipment,

(ii) Books
 and

Records, or
 (iii)
Both
	  	 Interest
	  	 Lessor/Property

Owner/Lessee

		  	 Songpa-gu, Seoul,

South Korea
	  	 Equipment (no other

Collateral is located
 at this
location)
	  		  	
					
	Endologix, Inc.	  	 Company’s sales
 representatives hold

Trunk Inventory in
 their possession for

sales calls and
 procedures, which

Trunk Inventory is not
 held at a specific

location or locations.
  

Certain Inventory of
 the Company is held

by numerous third
 parties on a

consignment basis at
 various locations.
	  	 Inventory

and/or
 Equipment (no other

Collateral is located
 at this
location)
  
 Inventory

and/or
 Equipment (no other

Collateral is located
 at this
location)
	  	 N.A.
  

 
 N.A.
	  	 N.A.
  

 
 N.A.

 SCHEDULE 5 

COMMERCIAL TORT CLAIMS 
 None. 

 SCHEDULE 6 

ACCOUNTS 
  

											
	ENTITY	  	COUNTRY	  	ACCT	  	CURR	  	BANK	  	USE
	Endologix, Inc.	  	US	  	XXXXX1702	  	USD	  	Bank of America	  	Operating account
	Endologix, Inc.	  	US	  	XXXXX1689	  	USD	  	Bank of America	  	Payroll account
	Endologix, Inc.	  	US	  	XXXXX5279	  	USD	  	Wells Fargo	  	Old Operating account
	Endologix, Inc.	  	US	  	XXXXX5311	  	USD	  	Wells Fargo	  	Old Payroll account
	Endologix, Inc.	  	US	  	XXXXX3910	  	USD	  	Bank of America	  	Lockbox account
	Endologix, Inc.	  	US	  	XXXXX4066	  	USD	  	Bank of America	  	Credit Card Cash Collateral account

 SCHEDULE 7 

REAL PROPERTY 
 None. 

 SCHEDULE 8 

COPYRIGHTS 
 None. 

 SCHEDULE 9 

INTELLECTUAL PROPERTY LICENSES 
  

	1.	 Inbound Master License Agreement, dated as of May 5, 2008, by and between SurModics, Inc. and Endologix,
Inc. 

  

	2.	 Inbound Development and OEM Device Supply Agreement, dated as of August 5, 2015, by and between Bard
Peripheral Vascular, Inc. and Endologix, Inc. 

  

	3.	 Inbound License Agreement, dated as of June 22, 2011, by and between NorMedix, LLC and Endologix, Inc.

  

	4.	 Inbound Settlement and Patent License Agreement, dated as of March 17, 2016, by and between LifePort
Sciences, LLC and Endologix, Inc. 

  

	5.	 Inbound License Agreement, dated as of July 23, 2013, by and between Thomas L. Fogarty and Endologix, Inc.

  

	6.	 Inbound Patent License and Settlement Agreement, dated June 4, 2019, by and between Endologix, Inc. and
Medtronic Vascular, Inc. 

 SCHEDULE 10 

PATENTS 
 See attached. 

 SCHEDULE 11 

TRADEMARKS 
 See attached.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]